Kaleyra 10-Q 15 May 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	May 12, 2020
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Entity Registrant Name	KALEYRA, INC.
Entity Central Index Key	0001719489
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		22,195,276
Entity Interactive Data Current	Yes
Entity File Number	001-38320
Entity Tax Identification Number	82-3027430
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	Via Marco D’Aviano, 2
Entity Address, City or Town	Milano MI
Entity Address, Country	IT
Entity Address, Postal Zip Code	20131
City Area Code	+39 02
Local Phone Number	288 5841
Document Quarterly Report	true
Document Transition Report	false
Common Stock, Par Value $0.0001 Per Share
Document Information [Line Items]
Title of Each Class	Common Stock, par value $0.0001 per share
Trading Symbol	KLR
Security Exchange Name	NYSEAMER
Warrants, at an Exercise Price of $11.50 per Share of Common Stock
Document Information [Line Items]
Title of Each Class	Warrants, at an exercise price of $11.50 per share of Common Stock
Trading Symbol	KLR WS
Security Exchange Name	NYSEAMER

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 16,237	$ 16,103
Restricted cash	20,810	20,894
Short-term investments	3,079	5,124
Trade receivables, net	36,307	39,509
Prepaid expenses	1,246	648
Other current assets	2,757	4,224
Total current assets	80,436	86,502
Property and equipment, net	3,888	3,393
Intangible assets, net	8,665	9,353
Goodwill	16,370	16,953
Other long-term assets	2,082	1,203
Total Assets	111,441	117,404
Current liabilities:
Accounts payable	56,674	63,320
Debt for forward share purchase agreements	31,530	34,013
Notes payable	2,113	1,667
Notes payable due to related parties	13,115	9,411
Lines of credit	5,278	3,627
Current portion of bank and other borrowings	5,925	7,564
Deferred revenue	1,538	1,397
Preference shares	1	683
Preference shares due to related parties	1	1,847
Payroll and payroll related accrued liabilities	2,929	1,038
Other current liabilities	2,023	1,379
Total current liabilities	121,127	125,946
Long-term portion of bank and other borrowings	20,621	16,134
Long-term portion of notes payable due to related parties	3,750	7,500
Long-term portion of employee benefit obligation	1,341	1,398
Deferred tax liabilities	1,638	2,045
Other long-term liabilities	4,599	3,155
Total Liabilities	153,076	156,178
Commitments and contingencies (Note 13)
Stockholders’ equity (deficit):
Preferred stock, par value of $0.0001 per share; 1,000,000 shares authorized; no shares issued or outstanding
Common stock, par value of $0.0001 per share; 100,000,000 shares authorized as of March 31, 2020 and December 31, 2019; 20,254,217 shares issued and 20,019,048 shares outstanding as of March 31, 2020 and 19,977,113 shares issued and outstanding as of December 31, 2019	2	2
Additional paid-in capital	11,190	2,143
Treasury stock, at cost; 235,169 and 0 shares as of March 31, 2020 and December 31, 2019, respectively	(2,587)
Accumulated other comprehensive income (loss)	(424)	74
Accumulated deficit	(49,816)	(40,993)
Total stockholders’ equity (deficit)	(41,635)	(38,774)
Total liabilities and stockholders’ equity (deficit)	$ 111,441	$ 117,404

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Statement Of Financial Position [Abstract]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	20,254,217	19,977,113
Common stock, shares outstanding	20,019,048	19,977,113
Treasury stock, shares	235,169	0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Revenue		$ 33,633,000	$ 27,725,000
Cost of revenue		28,902,000	22,476,000
Gross profit		4,731,000	5,249,000
Operating expenses:
Research and development		2,810,000	1,196,000
Sales and marketing		3,743,000	1,472,000
General and administrative		7,759,000	3,779,000
Total operating expenses		14,312,000	6,447,000
Loss from operations		(9,581,000)	(1,198,000)
Other income, net		42,000	82,000
Financial income (expense), net		(41,000)	70,000
Foreign currency income (loss)		168,000	(254,000)
Loss before income tax expense (benefit)		(9,412,000)	(1,300,000)
Income tax expense (benefit)		(589,000)	79,000
Net loss		$ (8,823,000)	$ (1,379,000)
Net loss per common share basic and diluted	[1]	$ (0.44)	$ (0.13)
Weighted-average shares used in computing net loss per common share basic and diluted	[1]	19,979,589	10,687,106
[1]	Amounts for the three months ended March 31, 2019 were retrospectively adjusted as a result of the accounting for the Business Combination (as defined below in the notes). Specifically, the number of common shares outstanding during periods before the Business Combination are computed on the basis of the number of common shares of Kaleyra S.p.A. (accounting acquiror) during those periods multiplied by the exchange ratio established in the stock purchase agreement. Common stock and net loss per share, basic and diluted were retrospectively adjusted accordingly.

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Statement Of Income And Comprehensive Income [Abstract]
Net loss		$ (8,823)	$ (1,379)
Other comprehensive income (loss):
Foreign currency translation adjustments		(502)	561
Net unrealized gain on marketable securities, net of tax	[1]	4	15
Total other comprehensive income (loss)		(498)	576
Total comprehensive loss		$ (9,321)	$ (803)
[1]	The Company recorded $1,000 and $5,000 of tax expense on unrealized gain on marketable securities for the three months ended March 31, 2020 and 2019, respectively.

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement Of Income And Comprehensive Income [Abstract]
Net unrealized gain on marketable securities, tax expense	$ 1,000	$ 5,000

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands		Total	Common Stock	Additional Paid-in Capital		Treasury Stock	Accumulated Other Comprehensive Income	Retained Earnings / (Accumulated Deficit)
Beginning balance at Dec. 31, 2018		$ 4,926	$ 1	$ 10,186	[1]		$ 31	$ (5,292)
Beginning balance, shares at Dec. 31, 2018	[1]		10,687,106
Net loss		(1,379)						(1,379)
Other comprehensive loss		576					576
Ending balance at Mar. 31, 2019		4,123	$ 1	10,186	[1]		607	(6,671)
Ending balance, shares at Mar. 31, 2019	[1]		10,687,106
Beginning balance at Dec. 31, 2019		(38,774)	$ 2	2,143			74	(40,993)
Beginning balance, shares at Dec. 31, 2019			19,977,113
Common stock repurchased in connection with forward share purchase agreements				2,587		$ (2,587)
Common stock repurchased in connection with forward share purchase agreements, shares			(235,169)			235,169
Change in forward share purchase agreement liability		(271)		(271)
Stock-based compensation (RSUs)		6,204		6,204
Stock-based compensation (RSUs), shares			137,104
Common stock issued to settle a payable	[2]	527		527
Common stock issued to settle a payable, shares	[2]		140,000
Net loss		(8,823)						(8,823)
Other comprehensive loss		(498)					(498)
Ending balance at Mar. 31, 2020		$ (41,635)	$ 2	$ 11,190		$ (2,587)	$ (424)	$ (49,816)
Ending balance, shares at Mar. 31, 2020			20,019,048			235,169
[1]	Amounts as of March 31, 2019 and before that date were retrospectively adjusted as a result of the accounting for the Business Combination (as defined in the notes). Specifically, the number of common shares outstanding during periods before the Business Combination are computed on the basis of the number of common shares of Kaleyra S.p.A. (accounting acquiror) during those periods multiplied by the exchange ratio established in the stock purchase agreement. Common stock and additional paid-in capital were adjusted accordingly.
[2]	On March 6, 2020, the Company issued to Northland Securities Inc. (“Northland”), 140,000 shares of the Company’s common stock as a partial settlement of the amounts owned to Northland for financial advisory services provided by Northland to Kaleyra S.p.A. in connection with the previously consummated Business Combination.

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) (Parenthetical)	Mar. 06, 2020shares
Northland Securities Inc
Common stock issued to settle a payable, shares	140,000

Condensed Consolidated Statem_6

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Cash Flows from Operating Activities:
Net loss		$ (8,823)	$ (1,379)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		638	650
Stock-based compensation and preference share liability		6,308	315
Non-cash settlement of preference share liability		(2,486)
Allowance for doubtful accounts		117	60
Employee benefit obligation		89	80
Non-cash interest expense		72	103
Deferred taxes		(323)	(398)
Change in operating assets and liabilities:
Trade receivables		1,710	534
Other current assets		1,111	(399)
Other long-term assets		(808)	(349)
Accounts payable		(5,694)	(3,690)
Other current liabilities		3,526	402
Deferred revenue		206	6
Long-term liabilities		1,505	434
Net cash used in operating activities		(2,852)	(3,631)
Cash Flows from Investing Activities:
Purchase of short-term investments		(3,179)	(684)
Sale of short-term investments		5,041	2,062
Purchase of property and equipment		(89)	(291)
Sale of property and equipment		16
Capitalized software development costs		(731)
Purchase of intangible assets		(6)	(5)
Net cash provided by investing activities		1,052	1,082
Cash Flows from Financing Activities:
Change in line of credit		1,721	528
Borrowings on term loans		8,800	696
Repayments on term loans		(5,463)	(553)
Repurchase of common stock in connection with forward share purchase agreements		2,587
Payments related to forward share purchase agreements		(167)
Net cash provided by financing activities		2,304	671
Effect of exchange rate changes on cash, cash equivalents and restricted cash		(454)	(47)
Net increase (decrease) in cash, cash equivalents and restricted cash		50	(1,925)
Cash, cash equivalents and restricted cash, beginning of period	[1]	36,997	8,207
Cash, cash equivalents and restricted cash, end of period	[1]	37,047	6,282
Supplemental disclosures of cash flow information:
Cash paid for interest		153	95
Cash paid for income taxes			$ 85
Non-cash financing activities:
Change in value of forward share purchase agreements		271
Common stock issued to settle a payable		423
Note payable issued to settle a payable		$ 400
[1]	As of March 31, 2020, includes $16.2 million of cash and cash equivalents and $20.8 million of restricted cash; as of December 31, 2019, includes $16.1 million of cash and cash equivalents and $20.9 million of restricted cash.

Condensed Consolidated Statem_7

Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Statement Of Cash Flows [Abstract]
Cash and cash equivalents	$ 16,237	$ 16,103
Restricted cash	$ 20,800	$ 20,900

Description of Organization and

Description of Organization and Business Operations	3 Months Ended
	Mar. 31, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Description of Organization and Business Operations	1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Kaleyra, Inc., formerly GigCapital, Inc., (“Kaleyra,” the “Company,” “we,” “us,” and “our” refer to Kaleyra, Inc. and all of its consolidated subsidiaries) was incorporated in Delaware on October 9, 2017. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. On December 12, 2017, the Company completed the initial closing of its initial public offering (the “Offering”) whereby the Company sold 12,500,000 Units at a price of $10.00 per Unit. On January 9, 2018, the Company completed the second closing of the Offering with the exercise of the over-allotment option with the consummation of the sale of an additional 1,875,000 Units at a price of $10.00 per Unit. Each Unit consisted of one share of the Company’s common stock, $0.0001 par value, three-fourths one-tenth On February 22, 2019, the Company entered into a stock purchase agreement (the “Stock Purchase Agreement”) by and among the Company, Kaleyra S.p.A., Shareholder Representative Services LLC, (the “Seller Representative”) as representative for the holders of the ordinary shares of Kaleyra S.p.A. immediately prior to the closing of the Business Combination, and all of the stockholders of all of the Kaleyra S.p.A. stock (collectively, such Kaleyra S.p.A. stockholders, the “Sellers”), for the purpose of the Company acquiring all of the shares of Kaleyra S.p.A. Kaleyra S.p.A. is a cloud communications software provider delivering secure Application Protocol Interfaces (“APIs”) and connectivity solutions in the API/Communication Platform as a Service or CPaaS market, headquartered in Milan, Italy and with operations in Italy, India, Dubai and the United States. Kaleyra S.p.A.’s solutions include identity authentication, mobile and voice notifications on transactions, and banking services authorizations, most notably via different integrated mobile channels through its platform. On November 25, 2019, the Business Combination with Kaleyra S.p.A. (the “Business Combination”) was completed. Effective as of the closing of the Business Combination, the Company changed its name to Kaleyra, Inc. Upon the consummation of the Business Combination, the Company also changed its fiscal year end to December 31st from its previous fiscal year ending September 30th, such change first being effective for its fiscal year ended December 31, 2019. For accounting purposes, Kaleyra S.p.A. was deemed the acquiror in the Business Combination. The Business Combination was accounted for as a reverse recapitalization in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). Under this method of accounting, Kaleyra, Inc. has been treated as the “acquired” company for financial reporting purposes. Accordingly, for accounting purposes, the Business Combination is treated as the equivalent of Kaleyra S.p.A. issuing stock for the net assets of Kaleyra, Inc., accompanied by a recapitalization. As a result of the accounting for the Business Combination, the number of common shares authorized and outstanding during periods prior to the Business Combination, have been retrospectively adjusted to reflect the exchange ratio established in the Business Combination. The common stock and additional paid-in capital have also been retrospectively adjusted accordingly. Specifically, the number of common shares outstanding during periods prior to the Business Combination are computed on the basis of the number of common shares of Kaleyra S.p.A. (accounting acquiror) during those periods multiplied by the exchange ratio established in the Stock Purchase Agreement. Accordingly, weighted-average shares outstanding for purposes of the net loss per share calculation have been retrospectively adjusted to reflect the exchange ratio established in the Business Combination. See Note 16 – Net Loss Per Share – for further details. Upon the closing of the Business Combination, the Company’s rights and Units ceased trading, and the Company’s common stock began trading on the NYSE American stock exchange under the symbol “KLR”. Furthermore, on December 2, 2019, Kaleyra’s warrants began trading on the NYSE American stock exchange as “KLR WS”.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying condensed consolidated financial statements of the Company are unaudited, and have been prepared in accordance with US GAAP for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, this interim quarterly financial report does not include all disclosures required by US GAAP. In the opinion of our management, the unaudited condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, considered necessary to present fairly the financial position, results of operations and cash flows of Kaleyra and our consolidated subsidiaries for all periods presented. The results of operations for the three months ended March 31, 2020 are not necessarily indicative of the results to be expected in the future or for the full fiscal year. It is recommended that these condensed consolidated financial statements be read in conjunction with our consolidated financial statements and the notes thereto included in our 2019 Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on April 22, 2020. These condensed consolidated financial statements have been prepared in conformity with US GAAP applicable for an “emerging growth company” as defined in the Jumpstart Our Business Startups Act (“JOBS Act”). The JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. In particular, an emerging growth company can delay the adoption of certain accounting standards until those standards would apply to private companies. For the purpose of these condensed consolidated financial statements, the Company availed itself of an extended transition period for complying with new or revised accounting standards and, as a result, did not adopt new or revised accounting standards on the relevant dates on which adoption of such standards is required for public companies. Liquidity In connection with Accounting Standards Update (“ASU”) 2014-15, Presentation of Financial Statements-Going Concern (Subtopic 205-40), Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern, the Company evaluated its ability to continue as a going concern. The Company has negative cash flows from operating activities, and its current liabilities exceed its current assets as of March 31, 2020. The condensed consolidated balance sheet as of March 31, 2020 includes total current assets of $80.4 million and total current liabilities of $121.1 million, resulting in net liabilities due within the next 12 months of $40.7 million. The Business Combination generated significant obligations including (i) $13.1 million of liabilities related to non-recurring Business Combination transaction related costs; (ii) $15.0 million of deferred consideration to sellers in the Business Combination transaction (iii) $13.2 million of net obligations under certain Shares Purchase Forward Agreements entered into by GigCapital, Inc. prior to the Business Combination; and (iv) $3.6 million of notes payable acquired as a result of the Business Combination. Management, concerned about the Company’s ability to fulfill these obligations, made the decision to evaluate opportunities to refinance or renegotiate some of its current obligations and, during the first four months of 2020 put in place several actions aimed to achieve such goal, including, among others: • the subscription of a new loan agreement with a bank that is currently a lender to the Company; • signing of two new line of credit facilities; • a refinanced loan that extended payment terms and provided additional funds; • the amendments of the repayment schedules of certain existing long-term financing agreements to postpone the amounts due in the next three to nine months of 2020; and • the renegotiation of the payment terms of a payable related to costs incurred in the Business Combination. Considering the effects of these actions and the typical financial cycle of Kaleyra, Kaleyra’s management believes that the Company’s cash, cash flows from operations, financings and amendments to agreements described above, and availability of borrowings, as described above, will be sufficient to support its planned operations for at least the next 12 months from the date these condensed consolidated financial statements were issued. Business seasonality The Company’s results are affected by the business cycles of its customer base, which generally results in stronger revenue in the fourth quarter of the financial year. We believe this variability is largely due to the market demand for our customers’ and/or business partners’ services due to higher levels of purchasing activity in the holiday season. As a result of our historically higher portion of sales in the fourth quarter of each year, our cost of revenue increases during such period relative to any increase in revenue. The increase in cost of revenue and other impacts of seasonality may affect profitability in a given quarter. Principles of Consolidation The condensed consolidated financial statements include the Company and its wholly owned subsidiaries, including Kaleyra S.p.A., Solutions Infini and Buc Mobile, which represent its major operations. All significant intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are used for, but not limited to, allowance for doubtful accounts; valuation of the Company’s stock-based awards; recoverability of long-lived and intangible assets; capitalization and useful life of the Company’s capitalized internal-use software development costs; fair value of acquired intangible assets and goodwill; accruals and contingencies, including tax related provision and valuation allowance on deferred taxes. Estimates are based on historical experience and on various assumptions that the Company believes are reasonable under current circumstances. However, future events are subject to change and best estimates and judgments may require further adjustments; therefore, actual results could differ materially from those estimates. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results and outcomes may differ from management’s estimates and assumptions due to risks and uncertainties, including uncertainty in the current economic environment due to the recent outbreak of a novel strain of the coronavirus (“COVID-19”). Concentration of Credit Risk Financial instruments that potentially expose the Company to a concentration of credit risk consist primarily of cash, restricted cash and cash equivalents, short-term investments and trade receivables. The Company maintains cash and cash equivalents and short-term investments with financial institutions that management believes are financially sound. The Company sells its services to a wide variety of customers. If the financial condition or results of operations of any significant customers deteriorate substantially, operating results could be adversely affected. To reduce credit risk, management performs ongoing credit evaluations of the financial condition of significant customers. The Company maintains reserves for estimated credit losses on customer accounts when considered necessary. Actual credit losses may differ from the Company’s estimates. In the three months ended March 31, 2020 and 2019, there were zero and one customer, respectively, that individually accounted for more than 10% of the Company’s consolidated total revenue. In the three months ended March 31, 2019, revenue generated by that one customer accounted for $3.1 million. As of March 31, 2020 and December 31, 2019, no individual customer accounted for more than 10% of the Company’s consolidated total trade receivables. Reclassifications Certain reclassifications have been made to the 2019 presentation to conform to the current period’s presentation, none of which had an effect on total assets, total liabilities, stockholders’ equity (deficit), or net loss. Recent Accounting Pronouncements In March 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-04 “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”, which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments in this ASU provide optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply to contract modifications that replace a reference rate (e.g. LIBOR) affected by reference rate reform and contemporaneous modifications of other contract terms related to the replacement of the reference rate (including contract modifications to add or change fallback provisions). The following optional expedients for applying the requirements of certain Topics or Industry Subtopics in the Codification are permitted for contracts that are modified because of reference rate reform and that meet certain scope guidance: (i) modifications of contracts within the scope of Topics 310, Receivables, and 470, Debt, should be accounted for by prospectively adjusting the effective interest rate; (ii) modifications of contracts within the scope of Topics 840, Leases, and 842, Leases, should be accounted for as a continuation of the existing contracts with no reassessments of the lease classification and the discount rate or remeasurements of lease payments. For other Topics or Industry Subtopics in the Codification, the amendments also include a general principle that permits an entity to consider contract modifications due to reference rate reform to be an event that does not require contract remeasurement at the modification date or reassessment of a previous accounting determination. When elected, the optional expedients for contract modifications must be applied consistently for all eligible contracts or eligible transactions within the relevant Topic or Industry Subtopic. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. The Company adopted the amendments, and the adoption did not have a material impact on its condensed consolidated financial statements. In March 2020, the FASB issued ASU 2020-03 “Codification Improvements to Financial Instruments”, which improve s various financial instruments Topics in the Codification in order to increase stakeholder awareness of the amendments and to expedite the improvement process. The amendments in this ASU clarify or address stakeholders’ specific issues as described below: i. Issue 1: Fair Value Option Disclosures: The amendments clarify that all entities are required to provide the fair value option disclosures in paragraphs 825-10-50-24 through 50-32. ii. Issue 2: Applicability of Portfolio Exception in Topic 820 to Nonfinancial Items: Paragraphs 820-10-35-2A(g) and 820-10-35-18L are amended to include the phrase nonfinancial items accounted for as derivatives under Topic 815 to be consistent with the previous amendments to Section 820-10-35. iii. Issue 3: Disclosures for Depository and Lending Institutions: The amendments clarify that the disclosure requirements in Topic 320 apply to the disclosure requirements in Topic 942 for depository and lending institutions. iv. Issue 4: Cross-Reference to Line-of-Credit or Revolving-Debt Arrangements Guidance in Subtopic 470-50: The amendments improve the understandability of the guidance. v. Issue 5: Cross-Reference to Net Asset Value Practical Expedient in Subtopic 820-10: The amendments improve the understandability of the guidance. vi. Issue 6: Interaction of Topic 842 and Topic 326: The amendments clarify that the contractual term of a net investment in a lease determined in accordance with Topic 842 should be the contractual term used to measure expected credit losses under Topic 326. vii. Issue 7: Interaction of Topic 326 and Subtopic 860-20: The amendments to Subtopic 860- 20 clarify that when an entity regains control of financial assets sold, an allowance for credit losses should be recorded in accordance with Topic 326. For Issue 1, 2, 4 and 5, for public business entities, the amendments are effective upon issuance of this final ASU. For all other entities, including emerging growth companies as defined in the JOBS Act, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years beginning after December 15, 2020. Early application is permitted. The Company is currently evaluating the impact of this standard on its consolidated financial statements. For Issue 3, the effective dates and transition requirements for the amendments are the same as the effective dates and transition requirements in ASU 2019-04, for the guidance related to the amendments in ASU 2016-01. The effective date of ASU 2019-04 for the amendments to ASU 2016-01 is for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company adopted the amendments in the three months period ended March 31, 2020, and the adoption did not have a material impact on its consolidated financial statements. For Issue 6 and 7, the effective dates and transition requirements for the amendments are the same as the effective dates and transition requirements in ASU 2016-13. For entities that have not adopted the amendments in ASU 2016-13, the effective dates and the transition requirements for these amendments are the same as the effective date and transition requirements in ASU 2016-13 which for an emerging growth company is in 2023. Early adoption is permitted in any interim period as long as the entity has adopted the amendments in ASU 2016-13. The Company is currently evaluating the impact of this standard on its consolidated financial statements. In February 2020, the FASB issued ASU 2020-02 “Financial Instruments—Credit Losses (Topic 326) and Leases (Topic 842), Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842). This ASU applies to all registrants that are creditors in loan transactions that, individually or in the aggregate, have a material effect on the registrant’s financial condition. This ASU guidance is applicable upon a registrant’s adoption of Accounting Standards Codification (“ASC”) Topic 326. On November 15, 2019, the FASB delayed the effective date of ASC Topic 326 for certain small public companies and other private companies. As amended, the effective date of ASC Topic 326 was delayed until fiscal years beginning after December 15, 2022 for U.S. Securities and Exchange Commission (“SEC”) filers that are eligible to be smaller reporting companies under the SEC’s definition, as well as private companies and not-for-profit entities. The Company is currently evaluating the impact of this standard on its consolidated financial statements. Moreover, the amendments in this ASU add a note to a SEC paragraph pursuant to the issuance of ASU 2019-10, Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates. The note added states that at the December 2019 AICPA National Conference on Current SEC and PCAOB Developments, the SEC staff announced that it would not object to a public business entity that otherwise would not meet the definition of a public business entity except for a requirement to include or the inclusion of its financial statements or financial information in another entity’s filing with the SEC adopting Topic 842 for fiscal years beginning after December 15, 2020, and interim periods within fiscal years beginning after December 15, 2021. This announcement is applicable only to public business entities that otherwise would not meet the definition of a public business entity except for a requirement to include or the inclusion of its financial statements or financial information in another entity’s filing with the SEC. This announcement is not applicable to other public business entities. In January 2020, the FASB issued ASU 2020-01 “Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)”, cla rifying the Interactions between Topic 321, Topic 323, and Topic 815. The amendments in this ASU clarify the interaction of the accounting for equity securities under Topic 321 and investments accounted for under the equity method of accounting in Topic 323 and the accounting for certain forward contracts and purchased options accounted for under Topic 815. The amendments clarify that: (a) an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with Topic 321 immediately before applying or upon discontinuing the equity method; (b) an entity should not consider whether, upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in Topic 323 or the fair value option in accordance with the financial instruments guidance in Topic 825. For public business entities, the amendments in this ASU are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. For all other entities, including emerging growth companies as defined in the JOBS Act, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Early adoption is permitted, including early adoption in an interim period, (1) for public business entities for periods for which financial statements have not yet been issued and (2) for all other entities for periods for which financial statements have not yet been made available for issuance. The Company is currently evaluating the impact of this standard on its consolidated financial statements. In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820) Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement”. The amendments under ASU 2018-13 remove, add, and modify certain disclosure requirements on fair value measurements in ASC 820. In particular, the following disclosure were added: (i) The changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period; (ii) The range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments are effective for all entities for fiscal years, and interim periods within those years, beginning after December 15, 2019. The amendments on changes in unrealized gains and losses, and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The Company adopted the amendments in the three months period ended March 31, 2020, and the adoption did not have a material impact on its condensed consolidated financial statements.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	3. FAIR VALUE MEASUREMENTS The following tables provide the assets and liabilities measured at fair value on a recurring basis as of March 31, 2020 and December 31, 2019 (in thousands): Fair Value Hierarchy as of March 31, 2020 Aggregate Level 1 Level 2 Level 3 Fair Value Assets: Certificates of deposit (1) $ — $ 3,079 $ — $ 3,079 Total Assets $ — $ 3,079 $ — $ 3,079 Liabilities: Interest Rate Swap (2) $ — $ 73 $ — $ 73 Preference shares (3) — — 2 2 Debt for forward share purchase agreements (4) — 31,530 — 31,530 Total Liabilities $ — $ 31,603 $ 2 $ 31,605 (1) Included in the condensed consolidated balance sheet line item “Short-term investments”, with maturity terms between 4 and 12 months held in India. (2) Included in the condensed consolidated balance sheet line item “Other long-term liabilities”. (3) The preference shares liability was previously estimated on the basis of present value of the expected future cash flows contractually due in connection with the achievement of specified levels of EBITDA of Solutions Infini for the year ended March 31, 2020. On March 9, 2020, the Company signed a modification of the 2018 Solutions Infini Purchase Agreement to reduce the price of the preference shares to be purchased from the eligible employees of Solutions Infini in July 2020 to their face value, amounting to Indian Rupee 10.0 per each preference share. (4) Based on the information available at the reporting date, debts for forward share purchase agreements have been determined as the present value to be paid at settlement in case the counterparty exercises the put option. Fair Value Hierarchy as of December 31, 2019 Aggregate Level 1 Level 2 Level 3 Fair Value Assets: Mutual funds (1) $ 5,124 $ — $ — $ 5,124 Total Assets $ 5,124 $ — $ — $ 5,124 Liabilities Interest Rate Swap (2) $ — $ 80 $ — $ 80 Preference shares (3) — — 2,530 2,530 Debt for forward share purchase agreements (4) — 34,013 — 34,013 Total Liabilities $ — $ 34,093 $ 2,530 $ 36,623 (1) Included in the condensed consolidated balance sheet line item “Short-term investments”. (2) Included in the condensed consolidated balance sheet line item “Other long-term liabilities”. (3) Based on the information available at the reporting date, the preference shares liability was estimated on the basis of present value of the expected future cash flows contractually due in connection with the achievement of specified levels of EBITDA of Solutions Infini for the year ended March 31, 2020. Such cash flows are contractually predetermined and the maximum pay-out was assumed in determining the estimate which is primarily based on the expected EBITDA sourced from the most updated business plan, which represents management best estimates and is significantly above the targeted EBITDA. Changes in the liability during the period are due to (i) compensation expense accrued on a straight-line basis during period; (ii) accrued interest expense due to the fact that the obligation will be settled in 2020; and (iii) exchange rate differences. No fair value changes were recognized during the period. If the actual EBITDA of Solutions Infini for the year ended March 31, 2020 was materially below its expected level, this would have resulted in a change of the preference shares liability. (4) Based on the information available at the reporting date, debt for forward share purchase agreements have been determined as the present value to be paid at settlement in case the counterparty exercises the put option. The values of short-term investments as of March 31, 2020 and as of December 31, 2019 were as follows (in thousands): As of March 31, As of December 31, 2020 2019 Cost Unrealized gains Unrealized losses Fair value Cost Unrealized gains Unrealized losses Fair value Mutual funds $ — $ — $ — $ — $ 5,129 $ 1 $ (6 ) $ 5,124 Certificates of deposit 3,079 — — 3,079 — — — — The following table presents changes during the three months ended March 31, 2020 in Level 3 assets and liabilities measured at fair value on a recurring basis (in thousands): Fair Value Beginning of Period Net Realized and Unrealized (Gains) Losses Included in Income Other Comprehensive (Income) Loss Purchases, Sales, Issuances and Settlements, Net Change in scope of consolidation Gross Transfers In Fair Value End of Period March 31, 2020 Liabilities: Preference shares $ 2,530 $ (2,486 ) $ (42 ) $ — $ — $ — $ 2 There were no transfers of liabilities into or out of Level 2 or Level 3 for the three months ended March 31, 2020 and the year ended December 31, 2019. Net realized and unrealized (gains) and losses included in income related to Level 3 liabilities shown above are reported in the condensed consolidated statements of operations as follows (in thousands): Research and development Sales and marketing General and administrative Financial income (expense), net Foreign currency Income (loss) Total Three months ended March 31, 2020 Liabilities: Preference shares $ (941 ) $ (372 ) $ (756 ) $ (417 ) $ — $ (2,486 ) Three months ended March 31, 2019 Liabilities: Preference shares 117 46 94 58 — 315

Derivative Financial Instrument

Derivative Financial Instrument	3 Months Ended
	Mar. 31, 2020
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	4. DERIVATIVE FINANCIAL INSTRUMENTS The gross notional amount of interest rate swap derivative contracts not designated as hedging instruments, outstanding as of March 31, 2020 and December 31, 2019, was €5.8 million ($6.3 million) and €6.3 million ($7.0 million), respectively. The amount and location of the gains (losses) in the condensed consolidated statements of operations related to derivative contracts is as follows (in thousands): Three Months Ended March 31, Derivatives Not Designed As Hedging Instruments Line Items 2020 2019 Interest Rate Swap Financial income (expense), net $ 7 $ (5 ) Foreign Exchange Forward Financial income (expense), net — 211 Total $ 7 $ 206 The following table presents the fair value and the location of derivative contracts reported in the condensed consolidated balance sheets (in thousands): As of March 31, As of December 31, Derivatives Not Designed As Hedging Instruments (1) Line Items 2020 2019 Interest Rate Swap Other long-term liabilities $ (73 ) $ (80 ) Total $ (73 ) $ (80 ) (1) For the classification of inputs used to evaluate the fair value of our derivatives, refer to “Note 3”.

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net	3 Months Ended
	Mar. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, Net	5. GOODWILL AND INTANGIBLE ASSETS, NET Goodwill Goodwill as of March 31, 2020 and December 31, 2019 was as follows (in thousands): Balance as of December 31, 2019 $ 16,953 Effect of exchange rate (583 ) Balance as of March 31, 2020 $ 16,370 Intangible assets, net Intangible assets consisted of the following (in thousands): As of March 31, 2020 As of December 31, 2019 Gross Accumulated amortization Net Gross Accumulated amortization Net Amortizable Intangible Assets: Developed technology $ 2,711 $ 1,080 $ 1,631 $ 2,775 $ 952 $ 1,823 Customer relationships 8,777 1,826 6,951 9,077 1,631 7,446 Patent 118 35 83 113 29 84 Total amortizable intangible assets $ 11,606 $ 2,941 $ 8,665 $ 11,965 $ 2,612 $ 9,353 Amortization expense was $422,000 and $449,000 for the three months ended March 31, 2020 and 2019, respectively. Total estimated future amortization expense as of is as follows (in thousands): As of March 31, 2020 2020 (remaining nine months) $ 1,221 2021 1,409 2022 1,138 2023 1,035 2024 834 2025 and thereafter 3,028 Total $ 8,665

Other Assets

Other Assets	3 Months Ended
	Mar. 31, 2020
Other Assets [Abstract]
Other Assets	6. OTHER ASSETS Other current assets consisted of the following (in thousands): As of March 31, As of December 31, 2020 2019 VAT receivables $ 1,132 $ 3,136 Receivables from suppliers 812 398 Credit for tax other than income tax 505 358 Income tax assets 254 270 Other receivables 54 62 Total other current assets $ 2,757 $ 4,224 Other long-term assets consisted of the following (in thousands): As of March 31, As of December 31, 2020 2019 Non-current income tax credit (advances and tax reduced at sources) $ 1,726 $ 1,029 Miscellaneous 356 174 Total other long-term assets $ 2,082 $ 1,203

Bank and Other Borrowings

Bank and Other Borrowings	3 Months Ended
	Mar. 31, 2020
Bank And Other Borrowings [Abstract]
Bank and Other Borrowings	7. BANK AND OTHER BORROWINGS Credit line facilities As of March 31, 2020, the Company had credit line facilities granted for a total amount of $6.6 million, of which $5.3 million had been used, including a credit revolving facility denominated in US Dollar for $1.0 million granted to Buc Mobile in January 2020. As of December 31, 2019, the Company had available credit line facilities denominated in Euro for $5.6 million, of which $3.6 million had been used. The credit lines denominated in Euro may be drawn upon at variable interest rates in the following range: 0.6% - 7.6%. The weighted average interest rate on the credit line facilities outstanding as of March 31, 2020, was 1.22%. As mentioned above, on January 23, 2020, Buc Mobile entered into a revolving credit facility with Intesa Sanpaolo S.p.A. for a total amount of $1 million to be used solely for the purpose of Buc Mobile general working capital needs. As of March 31, 2020, this revolving credit facility was drawn for $950,000. The average effective interest rate for the three months ended March 31, 2020 was 1.52%. Long-term bank and other borrowings Long-term bank and other borrowings consist of the following (in thousands): Interest Nominal Rate As of March 31, As of December 31, Interest As of March 31, As of December 31, 2020 2019 Maturity Contractual Rate 2020 2019 UniCredit S.p.A. (Line A Tranche (1) $ 3,219 $ 3,609 January 2023 Euribor 3 months + 3.10% 2.80 % 2.80 % UniCredit S.p.A. (Line A Tranche (2) 151 167 May 2023 Euribor 3 months + 3.10% 2.80 % 2.80 % UniCredit S.p.A. (Line B) 2,941 3,229 November 2023 Euribor 3 months + 2.90% 2.60 % 2.60 % UniCredit S.p.A. (Line C) 2,497 2,787 February 2023 Euribor 3 months + 3.90% 3.53 % 3.53 % Intesa Sanpaolo S.p.A. (Line 1) 834 988 October 2021 Euribor 3 months + 1.80% 1.88 % 1.88 % Intesa Sanpaolo S.p.A. (Line 2) 3,841 4,183 October 2023 Euribor 3 months + 2.60% 2.60 % 2.60 % UBI Banca S.p.A. (Line 1) 257 332 February 2021 1.25 % 1.25 % 1.25 % UBI Banca S.p.A. (Line 2) 1,198 1,499 April 2021 Euribor 3 months +1.95% 1.55 % 1.55 % Monte dei Paschi di Siena S.p.A. (Line 1) 457 521 April 2022 0.95 % 0.95 % 0.95 % Monte dei Paschi di Siena S.p.A. (Line 2) 2,190 — June 2023 1.50 % 1.50 % — Banco Popolare di Milano S.p.A. (Line 1) 1,312 1,336 June 2023 Euribor 3 months + 2.00% 2.00 % 2.00 % Banco Popolare di Milano S.p.A. (Line 2) — 3,893 September 2022 Euribor 3 months + 2.00% — 2.00 % Banco Popolare di Milano S.p.A. (Line 3) 6,517 — March 2024 Euribor 3 months + 3.00% 2.16 % — Simest 1 275 280 December 2022 0.50 % 0.50 % 0.50 % Simest 2 273 279 December 2022 0.50 % 0.50 % 0.50 % Simest 3 503 512 December 2022 0.50 % 0.50 % 0.50 % Finlombarda S.p.A. 81 83 December 2020 0.50 % 0.50 % 0.50 % Total bank and other borrowings 26,546 23,698 Less: current portion 5,925 7,564 Total long-term portion $ 20,621 $ 16,134 On March 11, 2020, Kaleyra S.p.A. entered into a 36-month unsecured loan agreement with Monte dei Paschi di Siena S.p.A. for $2.2 million (€2.0 million). The total amount of this new facility was drawn in full the same date. This facility bears interest at a fixed rate equal to 1.5%. On March 20, 2020, Kaleyra S.p.A. entered into a general unsecured loan agreement (the “BPM Loan Agreement”) with Banco BPM S.p.A. (formerly Banco Popolare di Milano S.p.A.) for a total of $6.5 million (€6.0 million). The BPM Loan Agreement includes a new financing of $2.7 million with the remaining balance used to pay off the original loan dated July 23, 2019, by and between Kaleyra S.p.A. and Banco BPM S.p.A. The BPM Loan Agreement has a maturity of 45 months from the date of disbursement and bears interest at a variable rate equal to the three-month Euribor plus a spread of 3.00%. The BPM Loan Agreement is to be repaid in 15 quarterly installments. The total amount of the BPM Loan Agreement, less amounts related to commissions, fees and expenses, was drawn in full the same date as the BPM Loan Agreement. On March 31, 2020, Kaleyra S.p.A. received the approval by Intesa Sanpaolo S.p.A. to postpone payment of the amounts due under the existing loans for the next 3 months. As a result of this approval the Company will postpone the payments of approximately $404,000 beyond December 31, 2020. Subsequent to March 31, 2020, Kaleyra S.p.A. received the approval to postpone the payment of the amounts due under the existing loans for the next 6 to 9 months by UniCredit, UBI Banca S.p.A. and Simest S.p.A. See Note 19 – Subsequent Events – for further details. As of March 31, 2020, all of the available long-term facilities were drawn in full. Interest expense on bank and other borrowings was $218,000 for the three months ended March 31, 2020 and $90,000 for the three months ended March 31, 2019. As of March 31, 2020, the Company is obliged to make payments as follows (in thousands): As of March 31, 2020 2020 (remaining nine months) $ 3,784 2021 9,330 2022 7,637 2023 5,339 2024 456 Total $ 26,546

Debt for Forward Share Purchase

Debt for Forward Share Purchase Agreements	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Debt for Forward Share Purchase Agreements	8. DEBT FOR FORWARD SHARE PURCHASE AGREEMENTS As of March 31, 2020, the Company’s debt for forward share purchase agreements amounted to $31.5 million and accrued interest amounted to $163,000. Greenhaven On September 27, 2019, the Company and Greenhaven Road Capital Fund 1, LP, a Delaware limited partnership (“Greenhaven Fund 1”), and Greenhaven Road Capital Fund 2, LP, a Delaware limited partnership (“Greenhaven Fund 2” and together with Greenhaven Fund 1, “Greenhaven”) entered into a forward share purchase agreement (the “Greenhaven Purchase Agreement”) pursuant to which the Company agreed to purchase the shares of its common stock into which Rights of the Company held by Greenhaven and any additional Rights that Greenhaven acquired, converted into shares upon the closing of the Business Combination as amended as of December 13, 2019 at the following prices: (1) $11.00 per share for the first 196,195 shares sold to the Company; (2) $10.70 per share for the next 250,000 shares sold to the Company; and (3) $10.50 per share for the next 550,000 shares sold to the Company. The Company agreed to purchase the shares on the later of the sixtieth day after the Closing of the Business Combination or January 1, 2020 (the “Greenhaven Purchase Closing Date”). In exchange for Kaleyra, Inc.’s commitment to acquire the shares on the Greenhaven Purchase Closing Date, each of Greenhaven Fund 1 and Greenhaven Fund 2 agreed to continue to hold, and not to offer, sell, contract to sell, pledge, transfer, assign, or otherwise dispose of, directly or indirectly, or hedge (including any transactions involving any derivative securities of Kaleyra, Inc. and including any short sales involving any of Kaleyra, Inc.’s securities), the Rights (including any additional Rights) held by Greenhaven, and any shares that such Rights (including any additional Rights) converted into, until the Greenhaven Purchase Closing Date, including not to tender the Rights (or any additional Rights) to Kaleyra, Inc. in response to any tender offer that Kaleyra, Inc. may commence for the Rights. As amended on December 13, 2019, notwithstanding anything to the contrary herein, the parties agreed that Greenhaven shall after the closing of the Business Combination have the right but not the obligation to sell its shares that the Rights converted into in blocks of at least 25,000 shares (the “Minimum Block Size Condition”) in the open market if the sale price exceeds $8.50 per share, or, without meeting the Minimum Block Size Condition, Greenhaven shall have the right but not the obligation to sell any or all of its shares that the Rights converted into in the open market if the share price equals or exceeds $10.50 per share. In furtherance of the foregoing, Greenhaven shall have the right to sell such shares at any time provided that the price received by Greenhaven (not including any commissions due by Greenhaven for the sale) is at least $10.50 (or at least $8.50 if Greenhaven meets the Minimum Block Size Condition). In the event that Greenhaven sells any shares (including any Additional Shares), at a sale price of less than $10.50, and provided that Greenhaven meets the Minimum Block Size Condition, it shall provide notice to the Company within three (3) Business Days of such sale, and such notice shall include the date of the sale, the number of shares sold, and confirmation that the sale price per share was greater than $8.50, and the Company shall pay Greenhaven in accordance with Greenhaven’s written instructions an amount equal to (x) the number of shares (including any Additional Shares) sold multiplied by (y) the amount by which $10.50 exceeds the sale price per share. Furthermore, the parties agreed that nothing in the Greenhaven Purchase Agreement shall prohibit Greenhaven from entering into a contract to purchase and/or sell warrants of Kaleyra, Inc. On January 23, 2020, the Company entered into Amendment No. 3 to the Greenhaven Forward Share Purchase Agreement (the “Greenhaven Amendment”). The Greenhaven Amendment provides that Greenhaven has the right to put its subject shares to the Company on the following dates and at the following purchase prices: (i) $11.00 per share for up to 248,963 shares to be sold to the Company on February 21, 2020; and (ii) $11.70 per share for the next 700,000 shares to be sold to the Company on August 30, 2020. Greenhaven may continue to sell its subject shares in the open market, at its sole discretion, as long as the sales price is above $8.50 per share. On February 20, 2020, the Company repurchased an aggregate of 235,169 of its common stock for $2.6 million. In addition, the Company paid Greenhaven $152,000 for the 60,996 shares that Greenhaven sold on the open market representing the amount at which the $11.00 exceeded the selling price. On August 30, 2020, the Company shall pay Greenhaven an amount equal to (1) the number of shares (including any Additional Shares) sold by Greenhaven in the open market between February 21, 2020 and August 30, 2020 multiplied by (2) the amount by which $11.70 exceeds the sale price per share. As of March 31, 2020, the Company’s debt in connection with the Greenhaven Purchase Agreement amounted to $8.2 million. Kepos Alpha Fund On October 1, 2019, the Company and Kepos Alpha Fund L.P., a Cayman Islands limited partnership (“KAF”), entered into a forward share purchase agreement (“KAF Purchase Agreement”) pursuant to which the Company agreed to purchase the shares of common stock of the Company into which the Rights of the Company held by KAF, including any additional Rights that KAF acquired, converted into upon the closing of the Business Combination. The KAF Purchase Agreement was amended the following day to provide that the total number of additional Rights that KAF may acquire is 3,750,000 Rights. As amended December 13, 2019, the KAF Purchase Agreement provides that the Company would purchase such shares at the following price: (1) $10.70 per share for the first 102,171 shares sold to the Company; and (2) $10.50 per share for the next 93,676 shares sold to the Company. The Company agreed to purchase the shares on the earlier of the sixtieth day after the Business Combination or February 15, 2020 (the “KAF Purchase Closing Date”). In exchange for the Company’s commitment to acquire the shares on the KAF Purchase Closing Date, KAF agreed to continue to hold, and not to offer, sell, contract to sell, pledge, transfer, assign, or otherwise dispose of, directly or indirectly, or hedge (including any transactions involving any derivative securities of Kaleyra, Inc. and including any short sales involving any of the Company’s securities), the Rights (including any additional Rights) held by KAF, and any shares that such Rights (including any additional Rights) converted into, until the KAF Purchase Closing Date, including not to tender the Rights (or any additional Rights) to the Company in response to any Tender Offer that the Company may commence for the Rights. As amended on December 13, 2019, notwithstanding anything to the contrary herein, the parties agreed that KAF shall after the closing of the Business Combination have the right but not the obligation to sell its shares that the Rights converted into in blocks of at least the Minimum Block Size Condition in the open market if the sale price exceeds $8.50 per share, or, without meeting the Minimum Block Size Condition, KAF shall have the right but not the obligation to sell any or all of its shares that the Rights converted into in the open market if the share price equals or exceeds $10.50 per share. In furtherance of the foregoing, KAF shall have the right to sell such shares at any time provided that the price received by KAF (not including any commissions due by KAF for the sale) is at least $10.50 (or at least $8.50 if KAF meets the Minimum Block Size Condition). In the event that KAF sells any shares (including any Additional Shares), at a sale price of less than $10.50, and provided that KAF meets the Minimum Block Size Condition, it shall provide notice to the Company within three (3) Business Days of such sale, and such notice shall include the date of the sale, the number of shares sold, and confirmation that the sale price per share was greater than $ 8.50 , and the Company shall pay KAF in accordance with KAF’s written instructions an amount equal to (x) the number of shares (including any Additional Shares) sold multiplied by (y) the amount by which $ 10.50 exceeds the sale price per share. Furthermore, the parties agreed that nothing in the KAF Purchase Agreement shall prohibit KAF from entering into a contract to purchase and/or sell warrants of the Company. On January 23, 2020, the Company entered into Amendment No. 3 to the KAF Forward Share Purchase Agreement and on April 7, 2020, the Company entered into Amendment No. 4 (the “KAF Amendments”). According to the last amendment, KAF has the right to put its subject shares to the Company on May 7, 2020 at a purchase price of: (i) $10.92 per share for the first 46,137 shares sold to the Company; and (ii) $10.82 per share for the next 93,676 Shares sold to the Company (collectively, the “KAF Share Purchase Price”). In the event the closing occurs after May 7, 2020, the KAF Share Purchase Price shall increase for the 93,676 shares sold to Kaleyra by 1% per full month until the closing date. KAF may elect, in its sole and absolute discretion, to extend the date on which it exercises its put right to a date that is provided upon 10 calendar days’ written notice. The KAF Amendments further provide that KAF may sell its subject shares in the open market, at its sole discretion, as long as the sales price is above $7.00 per share. In the event that KAF sells any shares (including any Additional Shares) at a sale price of less than $10.92 per share for the first 46,137 shares and $10.82 per share for the next 93,676 shares, the Company shall pay KAF an amount equal to (A) the number of shares (including any Additional Shares) sold multiplied by (B) the amount by which $10.92 or $10.82, as applicable, exceeds the sale price per share. Should the Company fail to make this payment, the Company shall, without prejudice or limitation to any other remedies available to KAF in law or equity, pay a penalty on such amount due at the rate of 18% per annum from the due date until the date of payment in full. From January 1, 2020 to March 31, 2020, KAF sold 6,034 shares on the open market. As of March 31, 2020, the Company’s debt in connection with the KAF Purchase Agreement amounted to $2.1 million. Yakira Capital Management On November 19, 2019, the Company and Yakira Capital Management, Inc. (“Yakira”) entered into a forward share purchase agreement (the “Yakira Purchase Agreement”) pursuant to which (i) Yakira may elect to sell and transfer to the Company, and the Company will purchase shares of common stock of the Company held by Yakira at the Business Combination Date (the “Yakira Shares”), and (ii) the Company will purchase the shares of common stock of the Company into which the Rights held by Yakira (the “Yakira Rights Shares”) were converted upon the Business Combination Date. At the Business Combination Date, Yakira held 439,299 rights, and 1,084,150 Yakira Shares. The Company agreed that it will purchase the Yakira Rights Shares from Yakira at $1.05 per Right (which reflects $10.50 per Yakira Rights Share) (the “Yakira Rights Share Purchase Price”) as soon as practicable on or after the later of the sixtieth day after the Business Combination Date or January 1, 2020 (the “Yakira Rights Shares Closing Date”). In exchange for the Company’s agreement to purchase the Yakira Rights Shares, Yakira agreed to continue to hold, and not offer, sell, contract to sell, pledge, transfer, assign, or otherwise dispose of, directly or indirectly, or hedge the Rights (including any transactions involving any derivative securities of Yakira and any Short Sales involving any of the Company’s securities), and any Yakira Rights Shares that the rights converted into, until the Yakira Rights Shares Closing Date, including not to tender the Rights to the Company in response to any Tender Offer that the Company may commence for the Rights. Yakira has the right to terminate the agreement for the Company to purchase the Yakira Rights Shares, without penalty, commencing on the thirtieth day after the Business Combination Date and ending on the day prior to the Yakira Rights Shares Closing Date, by giving written notice to the Company, in which case it will not be restricted after such time with respect to its ability to dispose of the Yakira Rights Shares (subject to the restrictions against transactions involving any derivative securities of the Company and any Short Sales involving any of the Company’s securities). Except as described below, Yakira also agreed to continue to hold, and not offer, sell, contract to sell, pledge, transfer, assign, or otherwise dispose of, directly or indirectly, or hedge (including any transactions involving any derivative securities of the Company and any short sales involving any of the Company’s securities) the Yakira Shares prior to the six month anniversary of the Business Combination Date. Yakira further agreed to not redeem any of the Yakira Shares in conjunction with the Company’s stockholders’ approval of the Business Combination. Notwithstanding anything to the contrary herein, commencing on the day after the Business Combination Date, Yakira may sell the Yakira Shares in the open market as long as the sales price is above $10.50 per Yakira Share. If Yakira still owns Yakira Shares as of the four-month anniversary of the Business Combination Date, Yakira may sell such Yakira Shares between the four-month anniversary and six month anniversary of the Business Combination Date to the Company for a per share price (the “Yakira Shares Purchase Price”) equal to (a) $10.5019, plus (b) $0.03 per share for each month (prorated for a partial month) following the Business Combination Date that Yakira has held the Yakira Shares. The closing of the sale of the Yakira Shares to the Company shall occur on the business day following the Company’s receipt of the Yakira Shares exercise notice (the “Yakira Shares Closing Date”). On the Yakira Shares Closing Date, Yakira shall deliver the Yakira Shares to the Company against receipt of the aggregate Yakira Shares Purchase Price, which shall be paid by wire transfer of immediately available funds from the escrow account described below. Yakira may instruct the Escrow Agent to release to Yakira an amount equal to the Shares Purchase Price multiplied by the number of Yakira Shares delivered to the Company from the escrow account on the Yakira Shares Closing Date for Yakira’s use without restriction. Following the Business Combination Date, the Company deposited into an escrow account with the Escrow Agent, subject to an escrow agreement, with a nationally chartered bank the amount of $11,576,509 related to Yakira. The Company’s purchase of the Yakira Shares will be made with funds from the escrow account attributed to the Yakira Shares. In the event that Yakira sells any Yakira Shares as provided for above, it shall provide notice to the Company within three business days of such sale, and the Company may promptly release from the escrow account for its use without restriction an amount equal to the pro rata portion of the escrow account attributed to the Yakira Shares which Yakira has sold. In the event that Yakira chooses not to sell to the Company any Yakira Shares that it owns as of the six-month anniversary of the Business Combination Closing Date, the Company may promptly release all remaining funds from the escrow account for its use without restriction. In the event that the Yakira Shares Purchase Price paid on the Yakira Shares Closing Date is less than $10.6819 per Yakira Share, following payment of the Yakira Shares Purchase Price to Yakira, the Company and Yakira shall deliver joint written instructions to the Escrow Agent to release to Kaleyra from the remaining funds in the escrow account an amount equal to the difference between the Yakira Shares Purchase Price and $10.6819 per share multiplied by the number of Yakira Shares delivered by Yakira, and the Escrow Agent shall promptly disburse such amount to the Company in accordance with the payment instructions. On February 7, 2020, the Yakira Purchase Agreement with Yakira was amended (the “First Yakira Amendment”). The First Yakira Amendment provides that the Company may be obligated to purchase some or all of the 43,930 Yakira Rights Shares if Yakira exercises an option to sell such shares to the Company at a purchase price of $10.93 per share (which is an increase from $10.50 per share) as soon as practicable on or after the six-month anniversary of the Business Combination Date. On May 9, 2020, the Company entered into a second amendment to the Yakira Purchase Agreement (the “Second Amendment”). The Second Amendment provides that the Company will purchase from Yakira its 43,930 Rights Shares as soon as practicable on or after December 31, 2020. Nothing in the Yakira Purchase Agreement prohibits or restricts Yakira with respect to the purchase or sale of the Company’s warrants. As of March 31, 2020, the Company’s debt in connection with the Yakira Purchase Agreement amounted to $12.1 million. On May 12, 2020, Yakira gave notice to the Company that it was electing to sell and transfer to the Company all of the 1,084,150 Yakira Shares, and the purchase price for such sale and transfer is $11,580,782. Glazer Capital, LLC On November 19, 2019, the Company and Glazer Capital, LLC (“Glazer”) entered into a forward share purchase agreement (the “Glazer Purchase Agreement”) pursuant to which Glazer may elect to sell and transfer to the Company, and the Company will purchase the shares of the common stock of the company held by Glazer ( the “Glazer Shares”) at a price of $10.6819 per share (the “Glazer Shares Purchase Price”). Glazer shall notify the Company in writing five business days prior to the six month anniversary of the Business Combination Date if it is not exercising its right to sell the Glazer Shares to the Company; otherwise, absent written notification to the contrary, Glazer shall be deemed to have exercised its right to sell all of its Glazer Shares to the Company. The Company will purchase the Glazer Shares from Glazer on the six-month In exchange for the Company’s commitment to purchase the Glazer Shares on the Glazer Shares Closing Date, Glazer agreed to continue to hold, and not offer, sell, contract to sell, pledge, transfer, assign, or otherwise dispose of, directly or indirectly, or hedge (including any transactions involving any derivative securities of the Company and any Short Sales involving any of the Company’s securities) the Glazer Shares prior to the six month anniversary of the Business Combination Date. Glazer further agreed that it will not redeem any of the Glazer Shares in conjunction with the Company’s stockholders’ approval of the Business Combination. As amended on December 13, 2019, notwithstanding anything to the contrary herein, the parties agreed that Glazer shall, commencing on the day after the Business Combination Closing Date, have the right but not the obligation to sell its shares (including any Additional Shares) in blocks of at least the Minimum Block Size Condition in the open market if the sale price exceeds $8.50 per share prior to payment of any commissions due by Glazer for the sale, or, without meeting the Minimum Block Size Condition, Glazer shall have the right but not the obligation to sell any or all of its Shares (including any Additional Shares) in the open market if the sale price exceeds $ 10.50 per share prior to payment of any commissions due by Glazer for such sale. Glazer shall give written notice to the Company of any sale of shares (including any Additional Shares) within three (3) Business Days following the date of such sale, and such notice shall include the date of the sale, the number of shares sold, and confirmation that the sale price per share was greater than $ 10.50 per share (or greater than $ 8.50 per Share provided that Glazer meets the Minimum Block Size Condition) prior to the payment of any commissions due by Glazer for the sale. Simultaneously with the closing of the Business Combination, the Company deposited $9,858,678 which is the aggregate amount necessary to purchase the Glazer Shares, into an escrow account with Continental Stock Transfer and Trust Company (the “Escrow Agent”), subject to the terms of an escrow agreement. The Company’s purchase of the Glazer Shares will be made with funds from the escrow account attributed to the Glazer Shares. In the event that Glazer sells any Glazer Shares as provided for above, it shall provide notice to the Company within three business days of such sale, and Glazer shall instruct the Escrow Agent to release from the escrow account for the Company’s use without restriction an amount equal to the pro rata portion of the escrow attributed to the Glazer Shares which Glazer has sold. In the event that Glazer chooses not to sell to the Company any Glazer Shares that it owns as of the six-month anniversary of the Business Combination Date, Glazer shall instruct the Escrow Agent to release all remaining funds from the escrow account for the Company’s use without restriction. Notwithstanding the Company’s commitment to deposit funds into the escrow account for the purchase of the Glazer Shares, Kaleyra, Inc. shall use its best efforts to enter into a letter of credit agreement for the issuance of a standby letter of credit for the benefit of Glazer with a bank acceptable to Glazer (the “Issuing Bank”) as soon as possible to replace the escrow account. When the letter of credit agreement is entered into, Glazer will instruct the Escrow Agent to deposit the funds held in the escrow account into the collateral account with the Issuing Bank. Concurrently with the execution of the letter of credit agreement, the Issuing Bank shall issue the letter of credit for the benefit of Glazer in the amount of the escrow account. Glazer shall drawdown from the letter of credit to satisfy the payment due to Glazer by the Company for the purchase of the Glazer Shares. In the event that Glazer sells any Glazer Shares pursuant to the sales price restriction set forth above, it shall provide notice to the Company and the Issuing Bank within three business days of such sale, and the Issuing Bank shall release from the collateral account an amount equal to the number of Glazer Shares sold multiplied by $10.6819 to the Company for the Company’s use without restriction, with a corresponding reduction in the amount of the letter of credit. In the event that Glazer elects not to sell to the Company any Glazer Shares, the Issuing Bank shall release all funds in the collateral account to the Company for the Company’s use without restriction and terminate the letter of credit. On January 7, 2020 the Company entered into a Letter of Credit and Reimbursement agreement with EagleBank for the benefit of Glazer and $9.3 million of funds were transferred from the escrow account to a collateral account with EagleBank as collateral for the Letter of Credit and Reimbursement agreement. Nothing in the Glazer Purchase Agreement prohibits or restricts Glazer with respect to the purchase or sale of the Company’s warrants. From January 1, 2020 to March 31, 2020, Glazer sold 5,800 shares on the open market and the Company paid Glazer $15,000 representing the amount at which $10.50 exceeded the selling price. As of March 31, 2020, the Company’s debt in connection with the Glazer Purchase Agreement amounted to $9.2 million. Nomura Global Financial Products On October 31, 2019, the Company entered into an agreement (the “Confirmation”) with Nomura Global Financial Products, Inc. (“NGFP”) for an OTC Equity Prepaid Forward Transaction (the “Forward Transaction”). Pursuant to the terms of the Confirmation, NGFP agreed to waive any redemption right that would require the redemption of shares that it holds at the Business Combination Date in exchange for a pro rata amount of the funds held in the Trust Account provided that the Business Combination date occurred prior to December 12, 2019. Rather, NGFP, at its sole discretion, may either sell such shares in one or more transactions, publicly or privately, at a market price of at least $10.50 per share, or hold such shares for a period of time following the consummation of the Business Combination, at which time the Company will be required to purchase from NGFP, and NGFP will be required to sell to the Company, any such shares not otherwise previously sold by NGFP. The Confirmation provides that the Forward Transaction with NGFP is for up to 2,000,000 shares of common stock. The actual number of shares held by NGFP at the Business Combination Date was 1,623,000 shares of common stock (the “Subject Shares”). The Confirmation provided that following the closing of the Business Combination, the Company transferred from the Trust Account an amount equal to (a) the aggregate number of the Subject Shares held by NGFP, multiplied by (b) the per share redemption price for shares of common stock out of the Trust Account (the “Forward Price”) (such actual aggregate cash amount, the “Prepayment Amount”), as a partial prepayment to NGFP of the amount to be paid to NGFP in settlement of the Forward Transaction upon the Valuation Date (as defined below) for the number of shares owned by NGFP at the closing of the Business Combination. The amount of the Prepayment Amount transferred to NGFP on November 25, 2019 was $17,044,584. After the Business Combination Date, NGFP may sell the Subject Shares at its sole discretion in one or more transactions, publicly or privately, at any time prior to the Original Valuation Date or Extended Valuation Date (each as defined below, and each a “Valuation Date”) at a price per Subject Share not less than the Forward Price. Any Subject Shares sold by NGFP during the term of the Transaction will cease to be Subject Shares. NGFP will give written notice to the Company of any sale of Subject Shares by NGFP within two business days of the date of such sale, such notice to include the date of the sale, the number of Subject Shares sold, and confirmation that the sale price per Subject Share was not less than the Forward Price. After the Business Combination Date, NGFP may also buy and sell additional shares for its own account or on behalf of third parties, and the pricing limitation set forth in the prior paragraph will not apply to any shares purchased after the closing of the Business Combination. On each quarterly anniversary of the Business Combination Date (any such date, a “Cash Settlement Date”), NGFP will terminate the transaction in whole or in part by reducing the number of Subject Shares for the Forward Transaction (the reduction being “Terminated Shares”). The number of Terminated Shares with respect to any Cash Settlement Date will equal the number of Subject Shares sold by NGFP since the prior Cash Settlement Date (or with respect to the first Cash Settlement Date, the closing of the Business Combination). NGFP will notify the Company of the expected number of Terminated Shares not less than ten days prior to the applicable Cash Settlement Date. On each Cash Settlement Date, NGFP will pay the Company an amount equal to the product of (A) the number of Terminated Shares and (B) the Forward Price. With effect from the Cash Settlement Date, the remaining number of Subject Shares for the Forward Transaction will be reduced by the Terminated Shares. The “Original Valuation Date” for the Forward Transaction will be the first anniversary of the closing of the Business Combination, provided that NGFP and the Company may, not later than ten days prior to the Original Valuation Date, agree, each in their sole discretion, to extend the Valuation Date to the second anniversary of the Business Combination (the “Extended Valuation Date”). At the Original Valuation Date or Extended Valuation Date, the Forward Transaction will be settled by NGFP delivering the remaining Subject Shares to the Company, and the Company paying NGFP an amount equal to the product of (x) the Forward Price, (y) the applicable Accrual Percentage (as defined below), and (z) the number of remaining Subject Shares. The “Accrual Percentage” is the product of (a) with respect to any settlement occurring on or before the Original Valuation Date, 2.75% per annum, and with respect to any settlement occurring after the Original Valuation Date, 3.50% per annum, and (b) the number of actual days divided by the number of days in a year beginning on the date of the Business Combination and ending on the applicable day of the settlement. For the three months ended March 31, 2020, financial expense amounted to $117,000.

Notes Payable

Notes Payable	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Notes Payable	9. NOTES PAYABLE Notes payable to the Sellers As consideration for the Business Combination, on November 25, 2019 the Company issued unsecured convertible promissory notes to each of Esse Effe and Maya in the amount of $6.0 million and $1.5 million, respectively, (the “Convertible Notes”) and also issued other unsecured promissory notes to each of Esse Effe and Maya in the identical respective amounts (the “Non-convertible Notes”). Convertible Notes As of March 31, 2020, the amount outstanding for Convertible Notes was $7.5 million and accrued interest on Convertible Notes was $76,000. Interest on the Convertible Notes will accrue at a fixed interest rate equal to the one-year US dollar LIBOR interest rate published in The Wall Street Journal on the Business Combination Date, plus a margin of one percent (1%) per annum. Interest will be due and payable annually on each of (1) the date which is the twelve-month anniversary of the Business Combination Date and (2) on the date which is the twenty-four-month anniversary of the Business Combination Date. All interest shall be computed on the basis of a 365-day year and the actual number of days elapsed. Fifty percent (50%) of the outstanding principal balance of these Notes will be due and payable on the fifteen-month anniversary of the Business Combination Date. The remaining outstanding principal balance of these Convertible Notes plus all accrued and unpaid interest and fees due under these Notes will be due and payable in full on the twenty-four-month anniversary of the Business Combination Date. In the event that the Company receives, at any time while principal on these Convertible Notes remains outstanding, cash proceeds of an equity financing (the “Financing”) in an amount not less than $50.0 million (the “Notes Financing Proceeds”), fifty percent (50%) of the outstanding principal balance of these Notes will be due and payable no later than ten business days after the Company receives such Notes Financing Proceeds. In the event of a Financing where at any time the Company receives cash proceeds of such Financing in an amount not less than $75.0 million (the “Payoff Financing Proceeds”), one hundred percent In the event that these Convertible Notes are not paid in full on or before the applicable Maturity Date, then at any time after the sixtieth business day after the Maturity Date, assuming payment in full has not been made prior to such date, the outstanding principal amount of these Notes, together with all accrued but unpaid interest on these Convertible Notes, may be converted into shares of Company common stock, in part or in whole, at the option of the holder of these Convertible Notes by providing written notice at least three business days prior to the date of conversion. A conversion of any portion of these Convertible Note into shares of Company common stock will be effected at a conversion price equal to the Current Market Price as of the date of such conversion (the “Conversion Price”). The term “Current Market Price” means, generally, the average VWAP for the twenty consecutive trading days ending on the date that is five trading days prior to the date of conversion. The term “VWAP” means, for any trading day, the volume weighted average trading price of the Company’s common stock for such trading day on the NYSE (or if the Company’s common stock is no longer traded on the NYSE, on such other exchange as the Company’s common stock is then traded). Non-convertible Notes As of March 31, 2020, the amount outstanding for Non-convertible Notes was $7.5 million and accrued interest on Non-convertible Notes was $76,000. Interest on the Non-convertible Notes shall accrue at a fixed interest rate equal to LIBOR plus a margin of one percent (1%) per annum, which interest rate as of the date hereof is one and ninety-one hundredths percent (1.91%). As used herein, “LIBOR” means the one-year US Dollar LIBOR interest rate published in The Wall Street Journal on the Business Combination Date. All interest shall be computed on the basis of a 365-day year and the actual number of days elapsed. The outstanding principal balance of the Non-convertible Notes, plus all accrued and unpaid interest and fees due under these notes, shall be due and payable, upon the receipt by the Company, whether in a debt or equity financing event by the Company (which may include the receipt of cash from third parties with which the Company has entered into forward share purchase agreements), of cash proceeds in an amount not less than $11.5 million (the “Financing Proceeds”), no later than ten (10) business days after the Company receives the Financing Proceeds. Notes payable - Other Prior to the closing of the Business Combination, the Company had issued to several of its stockholders or their affiliates various promissory notes that were due to be paid in full upon the closing of the Business Combination (such notes referred to collectively as either the “Extension Notes” or the “Working Capital Notes”). In conjunction with the completion of the Business Combination, the Company and each of GigAcquisitions, LLC (the “Sponsor”) and an affiliate of the Sponsor, GigFounders, LLC, agreed to amend and restate the Extension Notes and Working Capital Notes held by them to provide that in lieu of repaying such promissory notes in full upon the closing of the Business Combination, the outstanding principal balance of such amended and restated notes (the “Amended Extension Notes” and the “Amended Working Capital Notes”), plus all accrued and unpaid interest (as described below) and fees due under the Amended Extension Notes and Amended Working Capital Notes, shall, upon the receipt by the Company, whether in a debt or equity financing event by the Company (which may include the receipt of cash from third parties with which the Company has entered into forward share purchase agreements), of cash proceeds in an amount not less than $11.5 million (the “Financing Proceeds”), be due and payable no later than ten business days after the Company receives the Financing Proceeds. Interest on the Amended Extension Notes and Amended Working Capital Notes will accrue at a fixed interest rate equal to the one-year U.S. dollar LIBOR interest rate published in The Wall Street Journal on the closing of the Business Combination, which is one and ninety-one hundredths percent (1.91%), plus a margin of one percent (1%) per annum. All interest shall be computed on the basis of a 365-day year and the actual number of days elapsed. None of the Amended Extension Notes or Amended Working Capital Notes will be convertible into securities of the Company. On March 31, 2020, all of the other holders of Extension Notes and Working Capital Notes similarly agreed to amend and restate these notes to exchange them into Amended Extension Notes and Amended Working Capital Notes. As of March 31, 2020, the outstanding amount of the notes payable for these notes was $3.6 million of which $1.9 million was due to related parties. On March 6, 2020, the Company issued to Northland, a promissory note for the principal amount of $400,000 as a partial settlement of the amounts owned to Northland for financial advisory services provided by Northland to Kaleyra S.p.A. in connection with the previously consummated Business Combination. This note bears interest at the rate of 8.0% per annum and matures on December 31, 2020.

Preference Shares Liabilities

Preference Shares Liabilities	3 Months Ended
	Mar. 31, 2020
Preference Shares Liabilities [Abstract]
Preference Shares Liabilities	10. PREFERENCE SHARES LIABILITIES Preference shares liabilities amounting to $2,000 and $2.5 million as of March 31, 2020 and December 31, 2019, respectively, represent the Company’s obligation to purchase in 2020 the preference shares from certain employees of Solutions Infini as a part of the Solutions Infini 2018 Purchase Agreement. On March 9, 2020, the Company signed a modification of the 2018 Solutions Infini Purchase Agreement to reduce the price of the preference shares to be purchased from the eligible employees of Solutions Infini in July 2020 to their face value, amounting to Indian Rupee 10.0 per each preference share. As a result of this modification, the total preference shares obligation was reduced to Indian Rupee 132,000 ($2,000 at the March 31, 2020 exchange rate). On January 31, 2020, the Company agreed to pay to the eligible employees of the preference shares, performance bonuses for a total amount of $3.5 million (at the March 31, 2020 exchange rate), to be paid in 2020, as a replacement of the preference shares obligation. On March 24, 2020, given the prevailing situation of the COVID-19 pandemic both globally and in India, the Company agreed with two of the eligible employees to delay payment of their performance bonuses, for a total amount of $1.4 million (at the March 31, 2020 exchange rate), and evaluate the timeline for payment thereof at a later date.

Other Current and Long-Term Lia

Other Current and Long-Term Liabilities	3 Months Ended
	Mar. 31, 2020
Other Liabilities Disclosure [Abstract]
Other Current and Long-Term Liabilities	11. OTHER CURRENT AND LONG-TERM LIABILITIES Other current liabilities consisted of the following (in thousands): As of March 31, As of December 31, 2020 2019 Liabilities for tax other than income tax $ 1,038 $ 583 Social securities liabilities 184 256 Accrued financial interest 413 149 Other liabilities 388 391 Total other current liabilities $ 2,023 $ 1,379 Other long-term liabilities consisted of the following (in thousands): As of March 31, As of December 31, 2020 2019 Payable to supplier (1) $ 2,700 $ 2,700 Long-term performance bonuses 1,433 — Derivative contract liabilities 73 80 Other long-term liabilities 393 375 Total other long-term liabilities $ 4,599 $ 3,155 (1) This obligation was settled by issuance of a note payable on May 1, 2020, when the settlement agreement with the supplier was executed. Refer to Note 19 – Subsequent events – for further details.

Geographic Information

Geographic Information	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Geographic Information	12. GEOGRAPHIC INFORMATION Revenue by geographic area is determined on the basis of the location of the customer. The Company generates its revenue primarily in Italy and India. The following table sets forth revenue by geographic area for the three months ended March 31, 2020 and 2019 (in thousands): Three Months Ended March 31, 2020 2019 Italy $ 14,608 $ 13,408 India 8,893 8,171 United States 4,289 1,692 Europe (excluding Italy) 2,573 3,598 Rest of the world 3,270 856 Total $ 33,633 $ 27,725 Three Months Ended March 31, 2020 2019 Italy 43.4 % 48.4 % India 26.4 % 29.5 % United States 12.8 % 6.1 % Europe (excluding Italy) 7.7 % 13.0 % Rest of the world 9.7 % 3.0 % As of March 31, 2020, the majority of the Company’s long-lived assets are located in Italy. The following table sets forth long-lived assets by geographic area as of March 31, 2020 and December 31, 2019 (in thousands): As of March 31, As of December 31, 2020 2019 Italy $ 1,965 $ 1,772 India 1,115 1,162 United States 787 437 Rest of the world 21 22 Total $ 3,888 $ 3,393 As of March 31, As of December 31, 2020 2019 Italy 50.5 % 52.2 % India 28.7 % 34.2 % United States 20.3 % 12.9 % Rest of the world 0.5 % 0.7 %

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	13. COMMITMENTS AND CONTINGENCIES Lease Commitments The Company entered into various operating lease agreements that expire over various years in the next 7 years. The Company’s Milan office lease contains an option to renew the lease for 6 years under terms and conditions set forth in the lease agreement. Certain of the Company’s leases contain provisions for rental adjustments. Operating lease rentals are expensed on a straight-line basis over the life of the lease beginning on the date the Company takes possession of the property. Rent expense was $309,000 and $196,000 for the three months ended March 31, 2020 and 2019, respectively. Future minimum lease payments under operating leases as of March 31, 2020 are as follows (in thousands): As of March 31, 2020 2020 (remaining nine months) $ 541 2021 527 2022 508 2023 400 2024 312 2025 and thereafter 416 Total Minimum Lease Payments $ 2,704 Contingencies As of March 31, 2020, the Company had contingent liabilities of $126,000, relating to a tax appeal of Solutions Infini for which no provision was recognized as its occurrence was deemed remote.

Restricted Stock Units

Restricted Stock Units	3 Months Ended
	Mar. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Restricted Stock Units	14. RESTRICTED STOCK UNITS (RSUs) On March 24, 2020, the Board’s Compensation Committee approved the grant of 113,506 RSUs to a new manager of the Company. These RSUs have no performance conditions and vest as follows: (i) 25% of the shares vest on February 1, 2021 and (ii) the remaining 75% vests in equal quarterly installments over a three-year The following table sets forth the activity related to the number of outstanding RSUs for the three months ended March 31, 2020: Number of shares Weighted- average grant date fair value (per share) Non-vested as of December 31, 2019 3,336,095 $ 8.25 Vested (137,104 ) 8.25 Granted 113,506 6.23 Cancelled (132,897 ) 8.25 Non-vested as of March 31, 2020 3,179,600 $ 8.18 RSUs compensation expense for the three months ended March 31, 2020 was $6.2 million, which was recorded as follows (in thousands): Three Months Ended March 31, 2020 2019 Research and development $ 1,312 $ — Sales and marketing 1,053 — General and administrative 3,839 — Total $ 6,204 $ — As of March 31, 2020, there was $19.2 million of unrecognized compensation cost related to non-vested RSUs to be recognized over a weighted-average remaining period of 1.55 years.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	15. INCOME TAXES The Company provides for income taxes using an asset and liability approach under which deferred income taxes are provided for based upon enacted tax laws and rates applicable to periods in which the taxes become payable. The Company recorded an income tax benefit of $589,000 and an income tax expense $79,000 for the three months ended March 31, 2020 and 2019, respectively. As of March 31, 2020, the Company had $2.1 million of undistributed earnings and profits generated by a foreign subsidiary (Solutions Infini) for which no deferred tax liabilities have been recorded, since the Company intends to indefinitely reinvest such earnings in the subsidiary to fund the international operations and certain obligations of the subsidiary. Should the above undistributed earnings be distributed in the form of dividends or otherwise, the distributions would result in $321,000 of tax expense. The Company files income tax returns in the United States and in foreign jurisdictions including Italy, India, and Switzerland. As of March 31, 2020, the tax years 2007 through the current period remain open to examination in each of the major jurisdictions in which the Company is subject to tax.

Net Loss Per Share

Net Loss Per Share	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Net Loss Per Share	16. NET LOSS PER SHARE The Business Combination was accounted for as a reverse recapitalization in accordance with US GAAP. Accordingly, weighted average shares outstanding for purposes of the net loss per share calculation have been retrospectively adjusted to reflect the exchange ratio established in the Business Combination. The following table sets forth the calculation of basic and diluted net loss per share during the period presented (in thousands, except share and per share data): Three Months Ended March 31, 2020 2019 Net loss $ (8,823 ) $ (1,379 ) Weighted-average shares used to compute net loss per common share, basic and diluted 19,979,589 10,687,106 Net loss per common share, basic and diluted $ (0.44 ) $ (0.13 ) The Company generated a net loss for each of the three months ended March 31, 2020 and 2019. Accordingly, the effect of dilutive securities is not considered in the loss per share for such periods because their effect would be anti-dilutive on the net loss per share. For the three months ended March 31, 2020, the weighted-average number of outstanding shares of common stock equivalents, which were excluded from the calculation of the diluted net loss per share as their effect would be anti-dilutive, was 14,346,056 (zero for the three months ended March 31, 2019). Warrants Warrants will only be exercisable for whole shares at $11.50 per share. Under the terms of the Warrant agreement dated December 12, 2017, the Company has agreed to use its best efforts to file a new registration statement under the Securities Act, following the completion of the Business Combination, for the registration of the shares of common stock issuable upon exercise of the Warrants there were included in the Units. That registration statement was filed by the Company on May 4, 2020 and declared effective by the SEC on May 8, 2020. No fractional shares will be issued upon exercise of the Warrants. If, upon exercise of the Warrants, a holder would be entitled to receive a fractional interest in a share, the Company will, upon exercise, round down to the nearest whole number for the number of shares of common stock to be issued to the Warrant holder. Each Warrant became exercisable 30 days after the completion of the Business Combination and will expire five years after the completion of the Business Combination or earlier upon redemption or liquidation. If the Company is unable to deliver registered shares of common stock to the holder upon exercise of the Warrants during the exercise period, there will be no net cash settlement of these Warrants and the Warrants will expire worthless, unless they may be exercised on a cashless basis in the circumstances described in the Warrant agreement. Once the Warrants become exercisable, the Company may redeem the outstanding Warrants in whole and not in part at a price of $0.01 per Warrant upon a minimum of 30 days’ prior written notice of redemption, only in the event that the last sale price of the Company’s shares of common stock equals or exceeds $18.00 per share for any 20 trading days within the 30-trading day period ending on the third trading day before the Company sends the notice of redemption to the Warrant holders. As of March 31, 2020, there were 11,154,938 warrants outstanding.

Transactions with Related Parti

Transactions with Related Parties	3 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
Transactions with Related Parties	17. TRANSACTIONS WITH RELATED PARTIES During the three months ended March 31, 2020 and 2019, related party transactions, other than compensation and similar arrangements in the ordinary course of business, were as follows: i. Unsecured convertible promissory notes and unsecured non-convertible promissory notes, received by Esse Effe and Maya at the closing of the Business Combination, pursuant to the terms of the Stock Purchase Agreement. Maya is affiliated with Dario Calogero and the shares are beneficially owned by Mr. Calogero who is the Chief Executive Officer and a director of Kaleyra. Esse Effe is affiliated with a former director of the Company and which holds an interest in the Company. The outstanding amount due by the Company was $15.0 million plus $152,000 of accrued interest as of March 31, 2020 ($15.0 million plus $43,000 of accrued interest as of December 31, 2019). See Note 9 – Notes Payable – for additional information; ii. Unsecured promissory notes issued by the Company to the Sponsor and GigFounders, LLC. The outstanding amount due by the Company was $1.9 million. Accrued interest on these promissory notes amounted to $19,000 as of March 31, 2020 ($1.9 million and $5,000 of accrued interest as of December 31, 2019). See Note 9 – Notes Payable – for additional information; iii. Legal services rendered by a partner of Studio Legale Chiomenti, that is a family member of a key manager of the Company. Costs incurred by the Company for the above services were $56,000 and zero in the three months ended March 31, 2020 and 2019; iv. Loans granted to Company’s directors and executive managers (at the reporting date, also Company’s stockholders) whose outstanding amount was $21,000 and $22,000 as of March 31, 2020 and December 31, 2019, respectively; and v. As of March 31, 2020 and December 31, 2019, the outstanding obligation for preference shares due to executive managers was $1,000 and $1.8 million, respectively. As mentioned above, in the three months ended March 31, 2020, as a result of a modification of the 2018 Solutions Infini Purchase Agreement, a significant portion of the liability for preference shares was reversed to the statement of operations. See Note 10 – Preference Shares Liabilities – for further details. The following table presents the expenses for transactions with related parties reported in the condensed consolidated statements of operations (in thousands): Three Months Ended March 31, 2020 2019 Research and development $ — $ 94 General and administrative 56 94 Financial income (expense), net 122 —

Revenue

Revenue	3 Months Ended
	Mar. 31, 2020
Revenue From Contract With Customer [Abstract]
Revenue	18. REVENUE Revenue Recognition The Company enters into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. Revenue is recognized net of allowances for credits and any taxes collected from customers. Taxes collected are subsequently remitted to governmental authorities. The Company determines revenue recognition through the following steps: • Identification of the contract, or contracts, with a customer; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, the Company satisfies a performance obligation. Nature of Products and Services The Company's revenue is primarily derived from usage-based fees earned from the sale of communications services offered through software solutions to large enterprises, as well as small and medium-sized customers. The Company’s revenue is recognized upon the sending of a SMS message or by the authentication of a financial transaction of an end user of the Company’s customer using the Company’s platform in an amount that reflects the consideration the Company expects to receive in exchange for those services which is generally based upon agreed fixed prices per unit. Platform access is considered a monthly series comprised of one performance obligation and usage-based fees are recognized as revenue in the period in which the usage occurs. After usage occurs, there are no remaining obligations that would preclude revenue recognition. Revenue from usage-based fees represented 98% and 99% of total revenue, for the three months ended March 31, 2020 and 2019, respectively. Subscription-based fees are derived from certain term-based contracts, such as with the sales of short codes and customer support, which is generally one year. Term-based contract revenue is recognized on a ratable basis over the contractual term of the arrangement beginning on the date that the service is made available to the customer. Revenue from term-based fees represented 2% and 1% of total revenue for the three months ended March 31, 2020 and 2019, respectively. The Company's arrangements do not contain general rights of return. The contracts do not provide customers with the right to take possession of the software supporting the applications. Amounts that have been invoiced are recorded in trade receivables and in revenue or deferred revenue depending on whether the revenue recognition criteria have been met. Contract Balances The Company receives payments from customers based on a billing schedule as established in its contracts. Contract assets are recorded when the Company has a conditional right to consideration for its completed performance under the contracts. Trade receivables are recorded when the right to this consideration becomes unconditional, which is as usage occurs. The Company did not have any contract assets as of March 31, 2020 and December 31, 2019. Deferred revenue is recorded when cash payments are received in advance of future usage on non-cancellable contracts. As of March 31, 2020 and December 31, 2019, the Company recorded $1.5 million and $1.4 million, respectively, as deferred revenue in its condensed consolidated balance sheets. In the three months ended March 31, 2020, the Company recognized $647,000 of revenue that was included in the deferred revenue as of December 31, 2019. Disaggregated Revenue In general, revenue disaggregated by geography is aligned according to the nature and economic characteristics of the Company’s business and provides meaningful disaggregation of the Company’s results of operations. Refer to Note 12 – Geographic Information for details of revenue by geographic area.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	19. SUBSEQUENT EVENTS On April 7, 2020, Kaleyra S.p.A. received the approval by UBI Banca S.p.A. to postpone the amounts due under the existing loans for the next 6 months. As a result of this approval, the Company will postpone the payments of approximately $694,000 beyond the next 6 months. On April 9, 2020, Kaleyra S.p.A. received the approval by UniCredit to postpone the amounts due under the existing loans for the next 6 months. As a result of this approval, the Company will postpone the payments of approximately $1.6 million beyond the next 6 months. On April 9, 2020, the Company repurchased 50,000 shares of its common stock from KAF in connection with the KAP Amendments for a total purchase price of approximately $0.5 million. On April 16, 2020, in connection with the previously consummated Business Combination, the Company entered into a Settlement Agreement and Release (the “Settlement Agreement”) with its financial advisory service firms, Cowen and Company, LLC (“Cowen”) and Chardan Capital Markets, LLC, (“Chardan” and collectively the “Service Firms”), pursuant to which it agreed to pay an affiliate of Cowen, Cowen Investments II LLC (“Cowen Investments”), and Chardan, in full satisfaction of all amounts owed to the Service Firms as of December 31, 2019, $5.4 million in the aggregate, as follows: (i) $2.7 million in the aggregate in common stock of the Company (the “Settlement Shares”) to be issued the business day prior to the filing of a resale registration statement for such Settlement Shares (the “Resale Registration Statement”), (ii) convertible notes totaling $2.7 million in the aggregate with a maturity date three years after issuance and bearing interest at five percent (5%) per annum (but with lower interest rates if the notes are repaid earlier than one year or two years after issuance) and with interest paid in arrears to the payee on March 15, June 15, September 15 and December 15 of each year, with such convertible notes to also be issued the business day prior to the filing of the Resale Registration Statement and (iii) in the event that the Beneficial Ownership Limitation (as defined below) would otherwise be exceeded upon delivery of the Settlement Shares above, a warrant agreement also to be entered into with and issued to the Services Firms the business day prior to the filing of the Resale Registration Statement, whereby the amount of common stock of the Company by which the Beneficial Ownership Limitation would otherwise have been exceeded upon delivery of the Settlement Shares will be substituted for by warrants with an exercise price of $0.01 per share issued pursuant to a Warrant Agreement (the “Warrant Agreement”) and the common stock underlying the Warrant Agreement (the “Warrant Shares”). The Beneficial Ownership Limitation shall initially be 4.99% of the number of shares of the common stock outstanding of the Company immediately after giving effect to the issuance of these shares of common stock. The number of Settlement Shares shall be calculated using as the price per Settlement Share an amount equal to a fifteen percent (15%) discount to the ten-day (10-day) trailing dollar volume-weighted average price for the common stock of the Company on the NYSE American LLC stock exchange (the “VWAP”) on the business day immediately prior to the date on which Kaleyra files the Resale Registration Statement. In addition, the price per share for determining the number of shares of common stock of the Company to be issued upon the conversion of the convertible notes shall be a five percent (5%) premium to the ten-day (10-day) trailing VWAP as of the date immediately prior to the issuance date of the convertible notes, rounded down to the nearest whole number. On April 24, 2020, Kaleyra S.p.A. received the approval by Simest S.p.A. to postpone the amounts due under the existing loans in 2020. As a result of this approval, the Company will postpone the payments of approximately $350,000 beyond December 31, 2020. On April 29, 2020, the Company issued 1,763,633 shares (the “2019 Earnout Shares”) of the Company’s common stock, par value $0.0001 per share, at a fair value of $7.00 per share. On May 1, 2020, in connection with the Settlement Agreement, the Company issued: (i) an aggregate of 440,595 Settlement Shares to Cowen Investments and Chardan, consisting of 374,506 Settlement Shares issued to Cowen Investments, and 66,089 Settlement Shares issued to Chardan; and (ii) convertible promissory notes in the aggregate principal amount of $2.7 million to Cowen Investments and Chardan, consisting of a convertible promissory note in the principal amount of $ 2.3 million issued to Cowen Investments (the “Cowen Note”) and a convertible promissory note in the principal amount of $ 405,000 issued to Chardan (the “Chardan Note”), respectively. The unpaid principal of the Cowen Note is convertible at the option of Cowen Investments into 303,171 shares of common stock of the Company, if there has been no principal reduction, and the unpaid principal of the Chardan Note is convertible at the option of Chardan into 53,501 shares of common stock of the Company, if there has been no principal reduction. As the Beneficial Ownership Limitation was not triggered by the issuance of the Settlement Shares, no Warrant Agreement was necessary and no warrants were issued .

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying condensed consolidated financial statements of the Company are unaudited, and have been prepared in accordance with US GAAP for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, this interim quarterly financial report does not include all disclosures required by US GAAP. In the opinion of our management, the unaudited condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, considered necessary to present fairly the financial position, results of operations and cash flows of Kaleyra and our consolidated subsidiaries for all periods presented. The results of operations for the three months ended March 31, 2020 are not necessarily indicative of the results to be expected in the future or for the full fiscal year. It is recommended that these condensed consolidated financial statements be read in conjunction with our consolidated financial statements and the notes thereto included in our 2019 Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on April 22, 2020. These condensed consolidated financial statements have been prepared in conformity with US GAAP applicable for an “emerging growth company” as defined in the Jumpstart Our Business Startups Act (“JOBS Act”). The JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. In particular, an emerging growth company can delay the adoption of certain accounting standards until those standards would apply to private companies. For the purpose of these condensed consolidated financial statements, the Company availed itself of an extended transition period for complying with new or revised accounting standards and, as a result, did not adopt new or revised accounting standards on the relevant dates on which adoption of such standards is required for public companies.
Liquidity	Liquidity In connection with Accounting Standards Update (“ASU”) 2014-15, Presentation of Financial Statements-Going Concern (Subtopic 205-40), Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern, the Company evaluated its ability to continue as a going concern. The Company has negative cash flows from operating activities, and its current liabilities exceed its current assets as of March 31, 2020. The condensed consolidated balance sheet as of March 31, 2020 includes total current assets of $80.4 million and total current liabilities of $121.1 million, resulting in net liabilities due within the next 12 months of $40.7 million. The Business Combination generated significant obligations including (i) $13.1 million of liabilities related to non-recurring Business Combination transaction related costs; (ii) $15.0 million of deferred consideration to sellers in the Business Combination transaction (iii) $13.2 million of net obligations under certain Shares Purchase Forward Agreements entered into by GigCapital, Inc. prior to the Business Combination; and (iv) $3.6 million of notes payable acquired as a result of the Business Combination. Management, concerned about the Company’s ability to fulfill these obligations, made the decision to evaluate opportunities to refinance or renegotiate some of its current obligations and, during the first four months of 2020 put in place several actions aimed to achieve such goal, including, among others: • the subscription of a new loan agreement with a bank that is currently a lender to the Company; • signing of two new line of credit facilities; • a refinanced loan that extended payment terms and provided additional funds; • the amendments of the repayment schedules of certain existing long-term financing agreements to postpone the amounts due in the next three to nine months of 2020; and • the renegotiation of the payment terms of a payable related to costs incurred in the Business Combination. Considering the effects of these actions and the typical financial cycle of Kaleyra, Kaleyra’s management believes that the Company’s cash, cash flows from operations, financings and amendments to agreements described above, and availability of borrowings, as described above, will be sufficient to support its planned operations for at least the next 12 months from the date these condensed consolidated financial statements were issued.
Business seasonality	Business seasonality The Company’s results are affected by the business cycles of its customer base, which generally results in stronger revenue in the fourth quarter of the financial year. We believe this variability is largely due to the market demand for our customers’ and/or business partners’ services due to higher levels of purchasing activity in the holiday season. As a result of our historically higher portion of sales in the fourth quarter of each year, our cost of revenue increases during such period relative to any increase in revenue. The increase in cost of revenue and other impacts of seasonality may affect profitability in a given quarter.
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the Company and its wholly owned subsidiaries, including Kaleyra S.p.A., Solutions Infini and Buc Mobile, which represent its major operations. All significant intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are used for, but not limited to, allowance for doubtful accounts; valuation of the Company’s stock-based awards; recoverability of long-lived and intangible assets; capitalization and useful life of the Company’s capitalized internal-use software development costs; fair value of acquired intangible assets and goodwill; accruals and contingencies, including tax related provision and valuation allowance on deferred taxes. Estimates are based on historical experience and on various assumptions that the Company believes are reasonable under current circumstances. However, future events are subject to change and best estimates and judgments may require further adjustments; therefore, actual results could differ materially from those estimates. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results and outcomes may differ from management’s estimates and assumptions due to risks and uncertainties, including uncertainty in the current economic environment due to the recent outbreak of a novel strain of the coronavirus (“COVID-19”).
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially expose the Company to a concentration of credit risk consist primarily of cash, restricted cash and cash equivalents, short-term investments and trade receivables. The Company maintains cash and cash equivalents and short-term investments with financial institutions that management believes are financially sound. The Company sells its services to a wide variety of customers. If the financial condition or results of operations of any significant customers deteriorate substantially, operating results could be adversely affected. To reduce credit risk, management performs ongoing credit evaluations of the financial condition of significant customers. The Company maintains reserves for estimated credit losses on customer accounts when considered necessary. Actual credit losses may differ from the Company’s estimates. In the three months ended March 31, 2020 and 2019, there were zero and one customer, respectively, that individually accounted for more than 10% of the Company’s consolidated total revenue. In the three months ended March 31, 2019, revenue generated by that one customer accounted for $3.1 million. As of March 31, 2020 and December 31, 2019, no individual customer accounted for more than 10% of the Company’s consolidated total trade receivables.
Reclassifications	Reclassifications Certain reclassifications have been made to the 2019 presentation to conform to the current period’s presentation, none of which had an effect on total assets, total liabilities, stockholders’ equity (deficit), or net loss.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In March 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-04 “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”, which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments in this ASU provide optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply to contract modifications that replace a reference rate (e.g. LIBOR) affected by reference rate reform and contemporaneous modifications of other contract terms related to the replacement of the reference rate (including contract modifications to add or change fallback provisions). The following optional expedients for applying the requirements of certain Topics or Industry Subtopics in the Codification are permitted for contracts that are modified because of reference rate reform and that meet certain scope guidance: (i) modifications of contracts within the scope of Topics 310, Receivables, and 470, Debt, should be accounted for by prospectively adjusting the effective interest rate; (ii) modifications of contracts within the scope of Topics 840, Leases, and 842, Leases, should be accounted for as a continuation of the existing contracts with no reassessments of the lease classification and the discount rate or remeasurements of lease payments. For other Topics or Industry Subtopics in the Codification, the amendments also include a general principle that permits an entity to consider contract modifications due to reference rate reform to be an event that does not require contract remeasurement at the modification date or reassessment of a previous accounting determination. When elected, the optional expedients for contract modifications must be applied consistently for all eligible contracts or eligible transactions within the relevant Topic or Industry Subtopic. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. The Company adopted the amendments, and the adoption did not have a material impact on its condensed consolidated financial statements. In March 2020, the FASB issued ASU 2020-03 “Codification Improvements to Financial Instruments”, which improve s various financial instruments Topics in the Codification in order to increase stakeholder awareness of the amendments and to expedite the improvement process. The amendments in this ASU clarify or address stakeholders’ specific issues as described below: i. Issue 1: Fair Value Option Disclosures: The amendments clarify that all entities are required to provide the fair value option disclosures in paragraphs 825-10-50-24 through 50-32. ii. Issue 2: Applicability of Portfolio Exception in Topic 820 to Nonfinancial Items: Paragraphs 820-10-35-2A(g) and 820-10-35-18L are amended to include the phrase nonfinancial items accounted for as derivatives under Topic 815 to be consistent with the previous amendments to Section 820-10-35. iii. Issue 3: Disclosures for Depository and Lending Institutions: The amendments clarify that the disclosure requirements in Topic 320 apply to the disclosure requirements in Topic 942 for depository and lending institutions. iv. Issue 4: Cross-Reference to Line-of-Credit or Revolving-Debt Arrangements Guidance in Subtopic 470-50: The amendments improve the understandability of the guidance. v. Issue 5: Cross-Reference to Net Asset Value Practical Expedient in Subtopic 820-10: The amendments improve the understandability of the guidance. vi. Issue 6: Interaction of Topic 842 and Topic 326: The amendments clarify that the contractual term of a net investment in a lease determined in accordance with Topic 842 should be the contractual term used to measure expected credit losses under Topic 326. vii. Issue 7: Interaction of Topic 326 and Subtopic 860-20: The amendments to Subtopic 860- 20 clarify that when an entity regains control of financial assets sold, an allowance for credit losses should be recorded in accordance with Topic 326. For Issue 1, 2, 4 and 5, for public business entities, the amendments are effective upon issuance of this final ASU. For all other entities, including emerging growth companies as defined in the JOBS Act, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years beginning after December 15, 2020. Early application is permitted. The Company is currently evaluating the impact of this standard on its consolidated financial statements. For Issue 3, the effective dates and transition requirements for the amendments are the same as the effective dates and transition requirements in ASU 2019-04, for the guidance related to the amendments in ASU 2016-01. The effective date of ASU 2019-04 for the amendments to ASU 2016-01 is for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company adopted the amendments in the three months period ended March 31, 2020, and the adoption did not have a material impact on its consolidated financial statements. For Issue 6 and 7, the effective dates and transition requirements for the amendments are the same as the effective dates and transition requirements in ASU 2016-13. For entities that have not adopted the amendments in ASU 2016-13, the effective dates and the transition requirements for these amendments are the same as the effective date and transition requirements in ASU 2016-13 which for an emerging growth company is in 2023. Early adoption is permitted in any interim period as long as the entity has adopted the amendments in ASU 2016-13. The Company is currently evaluating the impact of this standard on its consolidated financial statements. In February 2020, the FASB issued ASU 2020-02 “Financial Instruments—Credit Losses (Topic 326) and Leases (Topic 842), Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842). This ASU applies to all registrants that are creditors in loan transactions that, individually or in the aggregate, have a material effect on the registrant’s financial condition. This ASU guidance is applicable upon a registrant’s adoption of Accounting Standards Codification (“ASC”) Topic 326. On November 15, 2019, the FASB delayed the effective date of ASC Topic 326 for certain small public companies and other private companies. As amended, the effective date of ASC Topic 326 was delayed until fiscal years beginning after December 15, 2022 for U.S. Securities and Exchange Commission (“SEC”) filers that are eligible to be smaller reporting companies under the SEC’s definition, as well as private companies and not-for-profit entities. The Company is currently evaluating the impact of this standard on its consolidated financial statements. Moreover, the amendments in this ASU add a note to a SEC paragraph pursuant to the issuance of ASU 2019-10, Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates. The note added states that at the December 2019 AICPA National Conference on Current SEC and PCAOB Developments, the SEC staff announced that it would not object to a public business entity that otherwise would not meet the definition of a public business entity except for a requirement to include or the inclusion of its financial statements or financial information in another entity’s filing with the SEC adopting Topic 842 for fiscal years beginning after December 15, 2020, and interim periods within fiscal years beginning after December 15, 2021. This announcement is applicable only to public business entities that otherwise would not meet the definition of a public business entity except for a requirement to include or the inclusion of its financial statements or financial information in another entity’s filing with the SEC. This announcement is not applicable to other public business entities. In January 2020, the FASB issued ASU 2020-01 “Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)”, cla rifying the Interactions between Topic 321, Topic 323, and Topic 815. The amendments in this ASU clarify the interaction of the accounting for equity securities under Topic 321 and investments accounted for under the equity method of accounting in Topic 323 and the accounting for certain forward contracts and purchased options accounted for under Topic 815. The amendments clarify that: (a) an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with Topic 321 immediately before applying or upon discontinuing the equity method; (b) an entity should not consider whether, upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in Topic 323 or the fair value option in accordance with the financial instruments guidance in Topic 825. For public business entities, the amendments in this ASU are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. For all other entities, including emerging growth companies as defined in the JOBS Act, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Early adoption is permitted, including early adoption in an interim period, (1) for public business entities for periods for which financial statements have not yet been issued and (2) for all other entities for periods for which financial statements have not yet been made available for issuance. The Company is currently evaluating the impact of this standard on its consolidated financial statements. In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820) Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement”. The amendments under ASU 2018-13 remove, add, and modify certain disclosure requirements on fair value measurements in ASC 820. In particular, the following disclosure were added: (i) The changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period; (ii) The range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments are effective for all entities for fiscal years, and interim periods within those years, beginning after December 15, 2019. The amendments on changes in unrealized gains and losses, and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The Company adopted the amendments in the three months period ended March 31, 2020, and the adoption did not have a material impact on its condensed consolidated financial statements.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following tables provide the assets and liabilities measured at fair value on a recurring basis as of March 31, 2020 and December 31, 2019 (in thousands): Fair Value Hierarchy as of March 31, 2020 Aggregate Level 1 Level 2 Level 3 Fair Value Assets: Certificates of deposit (1) $ — $ 3,079 $ — $ 3,079 Total Assets $ — $ 3,079 $ — $ 3,079 Liabilities: Interest Rate Swap (2) $ — $ 73 $ — $ 73 Preference shares (3) — — 2 2 Debt for forward share purchase agreements (4) — 31,530 — 31,530 Total Liabilities $ — $ 31,603 $ 2 $ 31,605 (1) Included in the condensed consolidated balance sheet line item “Short-term investments”, with maturity terms between 4 and 12 months held in India. (2) Included in the condensed consolidated balance sheet line item “Other long-term liabilities”. (3) The preference shares liability was previously estimated on the basis of present value of the expected future cash flows contractually due in connection with the achievement of specified levels of EBITDA of Solutions Infini for the year ended March 31, 2020. On March 9, 2020, the Company signed a modification of the 2018 Solutions Infini Purchase Agreement to reduce the price of the preference shares to be purchased from the eligible employees of Solutions Infini in July 2020 to their face value, amounting to Indian Rupee 10.0 per each preference share. (4) Based on the information available at the reporting date, debts for forward share purchase agreements have been determined as the present value to be paid at settlement in case the counterparty exercises the put option. Fair Value Hierarchy as of December 31, 2019 Aggregate Level 1 Level 2 Level 3 Fair Value Assets: Mutual funds (1) $ 5,124 $ — $ — $ 5,124 Total Assets $ 5,124 $ — $ — $ 5,124 Liabilities Interest Rate Swap (2) $ — $ 80 $ — $ 80 Preference shares (3) — — 2,530 2,530 Debt for forward share purchase agreements (4) — 34,013 — 34,013 Total Liabilities $ — $ 34,093 $ 2,530 $ 36,623 (1) Included in the condensed consolidated balance sheet line item “Short-term investments”. (2) Included in the condensed consolidated balance sheet line item “Other long-term liabilities”. (3) Based on the information available at the reporting date, the preference shares liability was estimated on the basis of present value of the expected future cash flows contractually due in connection with the achievement of specified levels of EBITDA of Solutions Infini for the year ended March 31, 2020. Such cash flows are contractually predetermined and the maximum pay-out was assumed in determining the estimate which is primarily based on the expected EBITDA sourced from the most updated business plan, which represents management best estimates and is significantly above the targeted EBITDA. Changes in the liability during the period are due to (i) compensation expense accrued on a straight-line basis during period; (ii) accrued interest expense due to the fact that the obligation will be settled in 2020; and (iii) exchange rate differences. No fair value changes were recognized during the period. If the actual EBITDA of Solutions Infini for the year ended March 31, 2020 was materially below its expected level, this would have resulted in a change of the preference shares liability. (4) Based on the information available at the reporting date, debt for forward share purchase agreements have been determined as the present value to be paid at settlement in case the counterparty exercises the put option.
Summary of Values of Short-term Investments	The values of short-term investments as of March 31, 2020 and as of December 31, 2019 were as follows (in thousands): As of March 31, As of December 31, 2020 2019 Cost Unrealized gains Unrealized losses Fair value Cost Unrealized gains Unrealized losses Fair value Mutual funds $ — $ — $ — $ — $ 5,129 $ 1 $ (6 ) $ 5,124 Certificates of deposit 3,079 — — 3,079 — — — —
Summary of Changes in Level 3 Assets and Liabilities Measured at Fair Value on Recurring Basis and Realized and Unrealized Gains (Losses)	The following table presents changes during the three months ended March 31, 2020 in Level 3 assets and liabilities measured at fair value on a recurring basis (in thousands): Fair Value Beginning of Period Net Realized and Unrealized (Gains) Losses Included in Income Other Comprehensive (Income) Loss Purchases, Sales, Issuances and Settlements, Net Change in scope of consolidation Gross Transfers In Fair Value End of Period March 31, 2020 Liabilities: Preference shares $ 2,530 $ (2,486 ) $ (42 ) $ — $ — $ — $ 2
Summary of Net Realized and Unrealized (Gains) and Losses Included in Income Related to Level 3 Liabilities	Net realized and unrealized (gains) and losses included in income related to Level 3 liabilities shown above are reported in the condensed consolidated statements of operations as follows (in thousands): Research and development Sales and marketing General and administrative Financial income (expense), net Foreign currency Income (loss) Total Three months ended March 31, 2020 Liabilities: Preference shares $ (941 ) $ (372 ) $ (756 ) $ (417 ) $ — $ (2,486 ) Three months ended March 31, 2019 Liabilities: Preference shares 117 46 94 58 — 315

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2020
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Schedule of Gain (Losses) in the Condensed Consolidated Statement of Operations Related to Derivative Contracts	The amount and location of the gains (losses) in the condensed consolidated statements of operations related to derivative contracts is as follows (in thousands): Three Months Ended March 31, Derivatives Not Designed As Hedging Instruments Line Items 2020 2019 Interest Rate Swap Financial income (expense), net $ 7 $ (5 ) Foreign Exchange Forward Financial income (expense), net — 211 Total $ 7 $ 206
Schedule of Fair Value Derivative Contracts Reported in Condensed Consolidated Balance Sheet	The following table presents the fair value and the location of derivative contracts reported in the condensed consolidated balance sheets (in thousands): As of March 31, As of December 31, Derivatives Not Designed As Hedging Instruments (1) Line Items 2020 2019 Interest Rate Swap Other long-term liabilities $ (73 ) $ (80 ) Total $ (73 ) $ (80 ) (1) For the classification of inputs used to evaluate the fair value of our derivatives, refer to “Note 3”.

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Net (Tables)	3 Months Ended
	Mar. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Summary of Goodwill	Goodwill as of March 31, 2020 and December 31, 2019 was as follows (in thousands): Balance as of December 31, 2019 $ 16,953 Effect of exchange rate (583 ) Balance as of March 31, 2020 $ 16,370
Summary of Intangible Assets	Intangible assets consisted of the following (in thousands): As of March 31, 2020 As of December 31, 2019 Gross Accumulated amortization Net Gross Accumulated amortization Net Amortizable Intangible Assets: Developed technology $ 2,711 $ 1,080 $ 1,631 $ 2,775 $ 952 $ 1,823 Customer relationships 8,777 1,826 6,951 9,077 1,631 7,446 Patent 118 35 83 113 29 84 Total amortizable intangible assets $ 11,606 $ 2,941 $ 8,665 $ 11,965 $ 2,612 $ 9,353
Summary of Estimated Future Amortization Expense	Total estimated future amortization expense as of is as follows (in thousands): As of March 31, 2020 2020 (remaining nine months) $ 1,221 2021 1,409 2022 1,138 2023 1,035 2024 834 2025 and thereafter 3,028 Total $ 8,665

Other Assets (Tables)

Other Assets (Tables)	3 Months Ended
	Mar. 31, 2020
Other Assets [Abstract]
Schedule of Other Current Assets	Other current assets consisted of the following (in thousands): As of March 31, As of December 31, 2020 2019 VAT receivables $ 1,132 $ 3,136 Receivables from suppliers 812 398 Credit for tax other than income tax 505 358 Income tax assets 254 270 Other receivables 54 62 Total other current assets $ 2,757 $ 4,224
Schedule of Other Long-Term Assets	Other long-term assets consisted of the following (in thousands): As of March 31, As of December 31, 2020 2019 Non-current income tax credit (advances and tax reduced at sources) $ 1,726 $ 1,029 Miscellaneous 356 174 Total other long-term assets $ 2,082 $ 1,203

Bank and Other Borrowings (Tabl

Bank and Other Borrowings (Tables)	3 Months Ended
	Mar. 31, 2020
Bank And Other Borrowings [Abstract]
Summary of Long-term Bank and Other Borrowings	Long-term bank and other borrowings Long-term bank and other borrowings consist of the following (in thousands): Interest Nominal Rate As of March 31, As of December 31, Interest As of March 31, As of December 31, 2020 2019 Maturity Contractual Rate 2020 2019 UniCredit S.p.A. (Line A Tranche (1) $ 3,219 $ 3,609 January 2023 Euribor 3 months + 3.10% 2.80 % 2.80 % UniCredit S.p.A. (Line A Tranche (2) 151 167 May 2023 Euribor 3 months + 3.10% 2.80 % 2.80 % UniCredit S.p.A. (Line B) 2,941 3,229 November 2023 Euribor 3 months + 2.90% 2.60 % 2.60 % UniCredit S.p.A. (Line C) 2,497 2,787 February 2023 Euribor 3 months + 3.90% 3.53 % 3.53 % Intesa Sanpaolo S.p.A. (Line 1) 834 988 October 2021 Euribor 3 months + 1.80% 1.88 % 1.88 % Intesa Sanpaolo S.p.A. (Line 2) 3,841 4,183 October 2023 Euribor 3 months + 2.60% 2.60 % 2.60 % UBI Banca S.p.A. (Line 1) 257 332 February 2021 1.25 % 1.25 % 1.25 % UBI Banca S.p.A. (Line 2) 1,198 1,499 April 2021 Euribor 3 months +1.95% 1.55 % 1.55 % Monte dei Paschi di Siena S.p.A. (Line 1) 457 521 April 2022 0.95 % 0.95 % 0.95 % Monte dei Paschi di Siena S.p.A. (Line 2) 2,190 — June 2023 1.50 % 1.50 % — Banco Popolare di Milano S.p.A. (Line 1) 1,312 1,336 June 2023 Euribor 3 months + 2.00% 2.00 % 2.00 % Banco Popolare di Milano S.p.A. (Line 2) — 3,893 September 2022 Euribor 3 months + 2.00% — 2.00 % Banco Popolare di Milano S.p.A. (Line 3) 6,517 — March 2024 Euribor 3 months + 3.00% 2.16 % — Simest 1 275 280 December 2022 0.50 % 0.50 % 0.50 % Simest 2 273 279 December 2022 0.50 % 0.50 % 0.50 % Simest 3 503 512 December 2022 0.50 % 0.50 % 0.50 % Finlombarda S.p.A. 81 83 December 2020 0.50 % 0.50 % 0.50 % Total bank and other borrowings 26,546 23,698 Less: current portion 5,925 7,564 Total long-term portion $ 20,621 $ 16,134
Summary of Payments Obliged	As of March 31, 2020, the Company is obliged to make payments as follows (in thousands): As of March 31, 2020 2020 (remaining nine months) $ 3,784 2021 9,330 2022 7,637 2023 5,339 2024 456 Total $ 26,546

Other Current and Long-Term L_2

Other Current and Long-Term Liabilities (Tables)	3 Months Ended
	Mar. 31, 2020
Other Liabilities Disclosure [Abstract]
Schedule of Other Current Liabilities	Other current liabilities consisted of the following (in thousands): As of March 31, As of December 31, 2020 2019 Liabilities for tax other than income tax $ 1,038 $ 583 Social securities liabilities 184 256 Accrued financial interest 413 149 Other liabilities 388 391 Total other current liabilities $ 2,023 $ 1,379
Schedule of Other Long-term Liabilities	Other long-term liabilities consisted of the following (in thousands): As of March 31, As of December 31, 2020 2019 Payable to supplier (1) $ 2,700 $ 2,700 Long-term performance bonuses 1,433 — Derivative contract liabilities 73 80 Other long-term liabilities 393 375 Total other long-term liabilities $ 4,599 $ 3,155 (1) This obligation was settled by issuance of a note payable on May 1, 2020, when the settlement agreement with the supplier was executed. Refer to Note 19 – Subsequent events – for further details.

Geographic Information (Tables)

Geographic Information (Tables)	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Summary of Revenue by Geographic Area	The following table sets forth revenue by geographic area for the three months ended March 31, 2020 and 2019 (in thousands): Three Months Ended March 31, 2020 2019 Italy $ 14,608 $ 13,408 India 8,893 8,171 United States 4,289 1,692 Europe (excluding Italy) 2,573 3,598 Rest of the world 3,270 856 Total $ 33,633 $ 27,725 Three Months Ended March 31, 2020 2019 Italy 43.4 % 48.4 % India 26.4 % 29.5 % United States 12.8 % 6.1 % Europe (excluding Italy) 7.7 % 13.0 % Rest of the world 9.7 % 3.0 %
Summary of Long-lived Assets by Geographic Area	The following table sets forth long-lived assets by geographic area as of March 31, 2020 and December 31, 2019 (in thousands): As of March 31, As of December 31, 2020 2019 Italy $ 1,965 $ 1,772 India 1,115 1,162 United States 787 437 Rest of the world 21 22 Total $ 3,888 $ 3,393 As of March 31, As of December 31, 2020 2019 Italy 50.5 % 52.2 % India 28.7 % 34.2 % United States 20.3 % 12.9 % Rest of the world 0.5 % 0.7 %

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2020
Commitments And Contingencies Disclosure [Abstract]
Schedule of Future Minimum Lease Payments under Operating Leases	Future minimum lease payments under operating leases as of March 31, 2020 are as follows (in thousands): As of March 31, 2020 2020 (remaining nine months) $ 541 2021 527 2022 508 2023 400 2024 312 2025 and thereafter 416 Total Minimum Lease Payments $ 2,704

Restricted Stock Units (Tables)

Restricted Stock Units (Tables) - Restricted Stock Units (RSUs)	3 Months Ended
	Mar. 31, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Summary of Outstanding RSUs	The following table sets forth the activity related to the number of outstanding RSUs for the three months ended March 31, 2020: Number of shares Weighted- average grant date fair value (per share) Non-vested as of December 31, 2019 3,336,095 $ 8.25 Vested (137,104 ) 8.25 Granted 113,506 6.23 Cancelled (132,897 ) 8.25 Non-vested as of March 31, 2020 3,179,600 $ 8.18
Summary of RSUs Compensation Expense	RSUs compensation expense for the three months ended March 31, 2020 was $6.2 million, which was recorded as follows (in thousands): Three Months Ended March 31, 2020 2019 Research and development $ 1,312 $ — Sales and marketing 1,053 — General and administrative 3,839 — Total $ 6,204 $ —

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Schedule of Calculation of Basic and Diluted Net Loss Per Share	The following table sets forth the calculation of basic and diluted net loss per share during the period presented (in thousands, except share and per share data): Three Months Ended March 31, 2020 2019 Net loss $ (8,823 ) $ (1,379 ) Weighted-average shares used to compute net loss per common share, basic and diluted 19,979,589 10,687,106 Net loss per common share, basic and diluted $ (0.44 ) $ (0.13 )

Transactions with Related Par_2

Transactions with Related Parties (Tables)	3 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
Schedule of Expenses for Related Parties	The following table presents the expenses for transactions with related parties reported in the condensed consolidated statements of operations (in thousands): Three Months Ended March 31, 2020 2019 Research and development $ — $ 94 General and administrative 56 94 Financial income (expense), net 122 —

Description of Organization a_2

Description of Organization and Business Operations - Additional Information (Details) - $ / shares	Jan. 18, 2018	Dec. 12, 2017	Mar. 31, 2020	Dec. 31, 2019
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Number of shares of common stock per unit		1
Common stock, par value		$ 0.0001	$ 0.0001	$ 0.0001
Initial Public Offering
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Units sold in offering		12,500,000
Sale of stock price per unit		$ 10
Second Closing of Offering
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Sale of stock price per unit	$ 10
Units sold in offering	1,875,000
Rights
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Percentage of receive/purchase one share of common stock		10.00%
Warrants
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Percentage of receive/purchase one share of common stock		75.00%
Business combination, share price		$ 11.50	$ 11.50

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Details) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2020USD ($)CreditFacilityCustomer	Mar. 31, 2019USD ($)Customer	Dec. 31, 2019USD ($)Customer
Schedule Of Significant Accounting Policies [Line Items]
Total current assets	$ 80,436		$ 86,502
Total current liabilities	121,127		$ 125,946
Net liabilities current	40,700
Business combination transaction related costs	13,100
Business combination, deferred consideration	15,000
Obligations net under shares purchase forward agreements entered by former entity	13,200
Business combination, notes payable acquired	$ 3,600
Number of new line of credit facilities | CreditFacility	2
Revenue	$ 33,633	$ 27,725
Customer Concentration Risk | Revenue
Schedule Of Significant Accounting Policies [Line Items]
Concentration risk percentage	10.00%	10.00%
Number of customers | Customer	0	1
Customer Concentration Risk | Trade Receivables
Schedule Of Significant Accounting Policies [Line Items]
Concentration risk percentage	10.00%		10.00%
Number of customers | Customer	0		0
Customer 1 | Customer Concentration Risk
Schedule Of Significant Accounting Policies [Line Items]
Revenue		$ 3,100
Minimum
Schedule Of Significant Accounting Policies [Line Items]
Long-term financing agreements, repayment schedule extension period	3 months
Maximum
Schedule Of Significant Accounting Policies [Line Items]
Long-term financing agreements, repayment schedule extension period	9 months

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - Recurring Basis - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Assets:
Total Assets	$ 3,079	$ 5,124
Liabilities:
Total Liabilities	31,605	36,623
Mutual Fund
Assets:
Total Assets		5,124
Interest Rate Swap
Liabilities:
Total Liabilities	73	80
Preference Shares
Liabilities:
Total Liabilities	2	2,530
Debt for Forward Share Repurchase Agreement
Liabilities:
Total Liabilities	31,530	34,013
Certificates of Deposit
Assets:
Total Assets	3,079
Level 1
Assets:
Total Assets		5,124
Level 1 | Mutual Fund
Assets:
Total Assets		5,124
Level 2
Assets:
Total Assets	3,079
Liabilities:
Total Liabilities	31,603	34,093
Level 2 | Interest Rate Swap
Liabilities:
Total Liabilities	73	80
Level 2 | Debt for Forward Share Repurchase Agreement
Liabilities:
Total Liabilities	31,530	34,013
Level 2 | Certificates of Deposit
Assets:
Total Assets	3,079
Level 3
Liabilities:
Total Liabilities	2	2,530
Level 3 | Preference Shares
Liabilities:
Total Liabilities	$ 2	$ 2,530

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Parenthetical) (Details)	3 Months Ended
	Mar. 31, 2020$ / shares	Feb. 29, 2020₨ / shares	Dec. 31, 2019$ / shares
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Preferred stock, par value | $ / shares	$ 0.0001		$ 0.0001
Modification of 2018 Solutions Infini Purchase Agreement | Solutions Infini
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Preferred stock, par value | ₨ / shares		₨ 10
Minimum
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Short term investments maturity term	4 months
Maximum
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Short term investments maturity term	12 months

Fair Value Measurements - Sum_3

Fair Value Measurements - Summary of Values of Short-term Investments (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Mutual Fund
Schedule Of Available For Sale Securities [Line Items]
Short-term investments, Cost		$ 5,129
Short-term investments, Unrealized gains		1
Short-term investments, Unrealized losses		(6)
Short-term investments, Fair value		$ 5,124
Certificates of Deposit
Schedule Of Available For Sale Securities [Line Items]
Short-term investments, Cost	$ 3,079
Short-term investments, Fair value	$ 3,079

Fair Value Measurements - Sum_4

Fair Value Measurements - Summary of Changes in Level 3 Assets and Liabilities Measured at Fair Value on Recurring Basis and Realized and Unrealized Gains (Losses) (Details) - Level 3 - Preference Shares - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Net Realized and Unrealized (Gains) Losses Included in Income	$ (2,486)	$ 315
Recurring Basis
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Fair Value Beginning of Period	2,530
Net Realized and Unrealized (Gains) Losses Included in Income	(2,486)
Other Comprehensive (Income) Loss	(42)
Fair Value End of Period	$ 2

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Fair Value Disclosures [Abstract]
Transfers of liabilities into or out of level 2 or level 3	$ 0	$ 0

Fair Value Measurements - Sum_5

Fair Value Measurements - Summary of Net Realized and Unrealized (Gains) and Losses Included in Income Related to Level 3 Liabilities (Details) - Level 3 - Preference Shares - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Net Realized and Unrealized (Gains) Losses Included in Income	$ (2,486)	$ 315
Research and Development
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Net Realized and Unrealized (Gains) Losses Included in Income	(941)	117
Sales and Marketing
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Net Realized and Unrealized (Gains) Losses Included in Income	(372)	46
General and Administrative
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Net Realized and Unrealized (Gains) Losses Included in Income	(756)	94
Financial Income (Expense), Net
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Net Realized and Unrealized (Gains) Losses Included in Income	$ (417)	$ 58

Derivative Financial Instrume_3

Derivative Financial Instruments - Additional Information (Details) € in Millions, $ in Millions	Mar. 31, 2020USD ($)	Mar. 31, 2020EUR (€)	Dec. 31, 2019USD ($)	Dec. 31, 2019EUR (€)
Interest Rate Swap | Not Designated as Hedging Instruments
Derivative Instruments Gain Loss [Line Items]
Derivative, notional amount	$ 6.3	€ 5.8	$ 7	€ 6.3

Derivative Financial Instrume_4

Derivative Financial Instruments - Schedule of Gain (Losses) in Condensed Consolidated Statement of Operations Related to Derivative Contracts (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Derivative Instruments Gain Loss [Line Items]
Total	$ 7	$ 206
Interest Rate Swap | Financial Income (Expense), Net
Derivative Instruments Gain Loss [Line Items]
Gain loss on interest rate derivative instruments	$ 7	(5)
Foreign Exchange Forward | Financial Income (Expense), Net
Derivative Instruments Gain Loss [Line Items]
Gain loss on Foreign exchange forward derivative instruments		$ 211

Derivative Financial Instrume_5

Derivative Financial Instruments - Schedule of Fair Value Derivative Contracts Reported in Condensed Consolidated Balance Sheet (Details) - Not Designated as Hedging Instruments - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Derivative Instruments Gain Loss [Line Items]
Derivative, total	$ (73)	$ (80)
Interest Rate Swap | Other Long-Term Liabilities
Derivative Instruments Gain Loss [Line Items]
Derivative on interest rate	$ (73)	$ (80)

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net- Summary of Goodwill (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)
Goodwill And Intangible Assets Disclosure [Abstract]
Balance as of December 31, 2019	$ 16,953
Effect of exchange rate	(583)
Balance as of March 31, 2020	$ 16,370

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net- Summary of Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Acquired Finite Lived Intangible Assets [Line Items]
Gross	$ 11,606	$ 11,965
Accumulated amortization	2,941	2,612
Net	8,665	9,353
Developed Technology
Acquired Finite Lived Intangible Assets [Line Items]
Gross	2,711	2,775
Accumulated amortization	1,080	952
Net	1,631	1,823
Customer Relationships
Acquired Finite Lived Intangible Assets [Line Items]
Gross	8,777	9,077
Accumulated amortization	1,826	1,631
Net	6,951	7,446
Patent
Acquired Finite Lived Intangible Assets [Line Items]
Gross	118	113
Accumulated amortization	35	29
Net	$ 83	$ 84

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Goodwill And Intangible Assets Disclosure [Abstract]
Amortization expense	$ 422,000	$ 449,000

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets, Net - Summary of Estimated Future Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Goodwill And Intangible Assets Disclosure [Abstract]
2020 (remaining nine months)	$ 1,221
2021	1,409
2022	1,138
2023	1,035
2024	834
2025 and thereafter	3,028
Net	$ 8,665	$ 9,353

Other Assets - Schedule of Othe

Other Assets - Schedule of Other Current Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Other Assets [Abstract]
VAT receivables	$ 1,132	$ 3,136
Receivables from suppliers	812	398
Credit for tax other than income tax	505	358
Income tax assets	254	270
Other receivables	54	62
Total other current assets	$ 2,757	$ 4,224

Other Assets - Schedule of Ot_2

Other Assets - Schedule of Other Long-Term Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Other Assets [Abstract]
Non-current income tax credit (advances and tax reduced at sources)	$ 1,726	$ 1,029
Miscellaneous	356	174
Total other long-term assets	$ 2,082	$ 1,203

Bank and Other Borrowings - Add

Bank and Other Borrowings - Additional Information (Details)	Mar. 31, 2020USD ($)	Mar. 20, 2020USD ($)	Mar. 11, 2020USD ($)	Mar. 31, 2020USD ($)	Mar. 31, 2019USD ($)	Mar. 20, 2020EUR (€)	Mar. 11, 2020EUR (€)	Jan. 23, 2020USD ($)	Dec. 31, 2019USD ($)
Bank And Other Borrowings [Line Items]
Line of credit facility, maximum borrowing capacity	$ 6,600,000			$ 6,600,000					$ 5,600,000
Line of credit facility, used	$ 5,300,000			$ 5,300,000					$ 3,600,000
Interest variable rates				1.00%
Weighted average interest rate	1.22%			1.22%
Interest expense				$ 218,000	$ 90,000
Minimum
Bank And Other Borrowings [Line Items]
Interest variable rates				0.60%
Maximum
Bank And Other Borrowings [Line Items]
Interest variable rates				7.60%
Kaleyra S.p.A | Intesa SanPaolo S.p.A.
Bank And Other Borrowings [Line Items]
Deferment of debt repayments beyond December 31, 2020	$ 404,000
Kaleyra S.p.A | Monte dei Paschi di Siena S.p.A. | Unsecured Loan Agreement
Bank And Other Borrowings [Line Items]
Debt instrument, term			36 months
Debt instrument face amount			$ 2,200,000				€ 2,000,000
Interest rate			1.50%				1.50%
Kaleyra S.p.A | Banco Popolare di Milano S.p.A. | BPM Loan Agreement
Bank And Other Borrowings [Line Items]
Interest variable rates		3.00%
Debt instrument, term		45 months
Debt instrument face amount		$ 6,500,000				€ 6,000,000
Description of variable rate		three-month Euribor plus a spread of 3.00%.
Frequency of periodic repayment		15 quarterly installments
Revolving Credit Facility | Intesa SanPaolo S.p.A.
Bank And Other Borrowings [Line Items]
Line of credit facility, used	$ 950,000			$ 950,000
Weighted average interest rate	1.52%			1.52%
Revolving Credit Facility | Buc Mobile
Bank And Other Borrowings [Line Items]
Line of credit facility, maximum borrowing capacity	$ 1,000,000			$ 1,000,000
Revolving Credit Facility | Buc Mobile | Intesa SanPaolo S.p.A.
Bank And Other Borrowings [Line Items]
Line of credit facility, maximum borrowing capacity								$ 1,000,000
New Financing | Kaleyra S.p.A | Banco Popolare di Milano S.p.A. | BPM Loan Agreement
Bank And Other Borrowings [Line Items]
Debt instrument face amount		$ 2,700,000

Bank and Other Borrowings - Sum

Bank and Other Borrowings - Summary of Long-term Bank and Other Borrowings (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Bank And Other Borrowings [Line Items]
Total Financial Liabilities	$ 26,546	$ 23,698
Less: current portion	5,925	7,564
Total long-term portion	$ 20,621	16,134
Contractual Interest Rate, Percentage	1.00%
Unicredit S.p.A. (Line A Tranche (1)
Bank And Other Borrowings [Line Items]
Total Financial Liabilities	$ 3,219	$ 3,609
Maturity	2023-01
Contractual Interest Rate	Euribor 3 months + 3.10%
Contractual Interest Rate, Percentage	3.10%
Interest Nominal Rate	2.80%	2.80%
Unicredit S.p.A. (Line A Tranche (2)
Bank And Other Borrowings [Line Items]
Total Financial Liabilities	$ 151	$ 167
Maturity	2023-05
Contractual Interest Rate	Euribor 3 months + 3.10%
Contractual Interest Rate, Percentage	3.10%
Interest Nominal Rate	2.80%	2.80%
Unicredit S.p.A. (Line B)
Bank And Other Borrowings [Line Items]
Total Financial Liabilities	$ 2,941	$ 3,229
Maturity	2023-11
Contractual Interest Rate	Euribor 3 months + 2.90%
Contractual Interest Rate, Percentage	2.90%
Interest Nominal Rate	2.60%	2.60%
Unicredit S.p.A. (Line C)
Bank And Other Borrowings [Line Items]
Total Financial Liabilities	$ 2,497	$ 2,787
Maturity	2023-02
Contractual Interest Rate	Euribor 3 months + 3.90%
Contractual Interest Rate, Percentage	3.90%
Interest Nominal Rate	3.53%	3.53%
Intesa San Paolo S.p.A. (Line 1)
Bank And Other Borrowings [Line Items]
Total Financial Liabilities	$ 834	$ 988
Maturity	2021-10
Contractual Interest Rate	Euribor 3 months + 1.80%
Contractual Interest Rate, Percentage	1.80%
Interest Nominal Rate	1.88%	1.88%
Intesa San Paolo S.p.A. (Line 2)
Bank And Other Borrowings [Line Items]
Total Financial Liabilities	$ 3,841	$ 4,183
Maturity	2023-10
Contractual Interest Rate	Euribor 3 months + 2.60%
Contractual Interest Rate, Percentage	2.60%
Interest Nominal Rate	2.60%	2.60%
UBI Banca S.p.A. (Line 1)
Bank And Other Borrowings [Line Items]
Total Financial Liabilities	$ 257	$ 332
Maturity	2021-02
Contractual Interest Rate, Percentage	1.25%
Interest Nominal Rate	1.25%	1.25%
UBI Banca S.p.A. (Line 2)
Bank And Other Borrowings [Line Items]
Total Financial Liabilities	$ 1,198	$ 1,499
Maturity	2021-04
Contractual Interest Rate	Euribor 3 months +1.95%
Contractual Interest Rate, Percentage	1.95%
Interest Nominal Rate	1.55%	1.55%
Monte dei Paschi di Siena S.p.A. (Line 1)
Bank And Other Borrowings [Line Items]
Total Financial Liabilities	$ 457	$ 521
Maturity	2022-04
Contractual Interest Rate, Percentage	0.95%
Interest Nominal Rate	0.95%	0.95%
Monte dei Paschi di Siena S.p.A. (Line 2)
Bank And Other Borrowings [Line Items]
Total Financial Liabilities	$ 2,190
Maturity	2023-06
Contractual Interest Rate, Percentage	1.50%
Interest Nominal Rate	1.50%
Banco Popolare di Milano S.p.A. (Line 2)
Bank And Other Borrowings [Line Items]
Total Financial Liabilities		$ 3,893
Maturity	2022-09
Contractual Interest Rate	Euribor 3 months + 2.00%
Contractual Interest Rate, Percentage	2.00%
Interest Nominal Rate		2.00%
Banco Popolare di Milano S.p.A. (Line 1)
Bank And Other Borrowings [Line Items]
Total Financial Liabilities	$ 1,312	$ 1,336
Maturity	2023-06
Contractual Interest Rate	Euribor 3 months + 2.00%
Contractual Interest Rate, Percentage	2.00%
Interest Nominal Rate	2.00%	2.00%
Banco Popolare di Milano S.p.A. (Line 3)
Bank And Other Borrowings [Line Items]
Total Financial Liabilities	$ 6,517
Maturity	2024-03
Contractual Interest Rate	Euribor 3 months + 3.00%
Contractual Interest Rate, Percentage	3.00%
Interest Nominal Rate	2.16%
Simest 1
Bank And Other Borrowings [Line Items]
Total Financial Liabilities	$ 275	$ 280
Maturity	2022-12
Contractual Interest Rate, Percentage	0.50%
Interest Nominal Rate	0.50%	0.50%
Simest 2
Bank And Other Borrowings [Line Items]
Total Financial Liabilities	$ 273	$ 279
Maturity	2022-12
Contractual Interest Rate, Percentage	0.50%
Interest Nominal Rate	0.50%	0.50%
Simest 3
Bank And Other Borrowings [Line Items]
Total Financial Liabilities	$ 503	$ 512
Maturity	2022-12
Contractual Interest Rate, Percentage	0.50%
Interest Nominal Rate	0.50%	0.50%
Finlombarda S.p.A.
Bank And Other Borrowings [Line Items]
Total Financial Liabilities	$ 81	$ 83
Maturity	2020-12
Contractual Interest Rate, Percentage	0.50%
Interest Nominal Rate	0.50%	0.50%

Bank and Other Borrowings - S_2

Bank and Other Borrowings - Summary of Payments Obliged (Details) $ in Thousands	Mar. 31, 2020USD ($)
Bank And Other Borrowings [Abstract]
2020 (remaining nine months)	$ 3,784
2021	9,330
2022	7,637
2023	5,339
2024	456
Total	$ 26,546

Debt for Forward Share Purcha_2

Debt for Forward Share Purchase Agreements - Additional Information (Details) - USD ($)

Aug. 30, 2020

May 12, 2020

May 09, 2020

May 07, 2020

Apr. 09, 2020

Apr. 07, 2020

Feb. 21, 2020

Feb. 20, 2020

Feb. 07, 2020

Dec. 13, 2019

Nov. 25, 2019

Nov. 19, 2019

Oct. 31, 2019

Oct. 01, 2019

Mar. 31, 2020

Mar. 31, 2019

Jan. 23, 2020

Jan. 07, 2020

Debt Instrument [Line Items]

Financial expense

$ (41,000)

$ 70,000

Kepos Alpha Fund L.P. | Subsequent Event

Debt Instrument [Line Items]

Repurchases of common stock, shares

50,000

Repurchases of common stock, value

$ 500,000

Forward Share Purchase Agreements

Debt Instrument [Line Items]

Debt Instrument, carrying amount

31,500,000

Accrued interest

$ 163,000

Forward Share Purchase Agreements | Greenhaven

Debt Instrument [Line Items]

Business combination, share price

$ 11

$ 11

Business combination payment for stock purchased

$ 152,000

Business combination payment for number of stock purchased

60,996

Forward Share Purchase Agreements | Greenhaven | Scenario Forecast

Debt Instrument [Line Items]

Business combination, share price

$ 11.70

Business combination, shares acquired

700,000

Forward Share Purchase Agreements | Greenhaven | Common Stock

Debt Instrument [Line Items]

Repurchases of common stock, shares

235,169

Repurchases of common stock, value

$ 2,600,000

Closing of business combination share consideration

6,034

Forward Share Purchase Agreements | Greenhaven | Maximum

Debt Instrument [Line Items]

Business combination, shares acquired

248,963

Forward Share Purchase Agreements | Greenhaven Road Capital Fund 1, LP

Debt Instrument [Line Items]

Debt Instrument, carrying amount

$ 8,200,000

Forward Share Purchase Agreements | Kepos Alpha Fund L.P.

Debt Instrument [Line Items]

Debt Instrument, carrying amount

2,100,000

Business combination, shares acquired

3,750,000

Forward Share Purchase Agreements | Kepos Alpha Fund L.P. | Subsequent Event

Debt Instrument [Line Items]

Percentage of increase in share purchase price

1.00%

Percentage of penalty payments

18.00%

Forward Share Purchase Agreements | Yakira

Debt Instrument [Line Items]

Debt Instrument, carrying amount

12,100,000

Forward Share Purchase Agreements | Yakira | Yakira Rights Shares

Debt Instrument [Line Items]

Business combination, share price

$ 1.05

Closing of business combination share consideration

439,299

Purchase price per share

$ 10.50

Forward Share Purchase Agreements | Yakira | Yakira Shares

Debt Instrument [Line Items]

Sale of stock price per unit

$ 10.5019

Closing of business combination share consideration

1,084,150

Sale of stock description

Yakira still owns Yakira Shares as of the four-month anniversary of the Business Combination Date, Yakira may sell such Yakira Shares between the four-month anniversary and six month anniversary of the Business Combination Date to the Company for a per share price (the “Yakira Shares Purchase Price”) equal to (a) $10.5019, plus (b) $0.03 per share for each month (prorated for a partial month) following the Business Combination Date that Yakira has held the Yakira Shares.

Sale of stock basis spread per month on price per share

$ 0.03

Deposited in escrow account

$ 11,576,509

Share Purchases Price Multiplied By Number Of Share

$ 10.6819

Forward Share Purchase Agreements | Yakira | Subsequent Event

Debt Instrument [Line Items]

Closing of business combination share consideration

1,084,150

Business combination, purchase price

$ 11,580,782

Forward Share Purchase Agreements | Yakira | Minimum | Yakira Shares

Debt Instrument [Line Items]

Sale of stock price per unit

10.50

Forward Share Purchase Agreements | Yakira | Maximum | Yakira Shares

Debt Instrument [Line Items]

Business combination, share price

10.6819

Forward Share Purchase Agreements | Glazer Capital, LLC

Debt Instrument [Line Items]

Debt Instrument, carrying amount

$ 9,200,000

Business combination, share price

$ 10.6819

$ 10.50

Business combination payment for stock purchased

$ 15,000

Business combination, shares issued description

Glazer shall notify the Company in writing five business days prior to the six month anniversary of the Business Combination Date if it is not exercising its right to sell the Glazer Shares to the Company; otherwise, absent written notification to the contrary, Glazer shall be deemed to have exercised its right to sell all of its Glazer Shares to the Company. The Company will purchase the Glazer Shares from Glazer on the six-month anniversary of the closing of the Business Combination (the “Glazer Shares Closing Date”). As of the Business Combination Date, Glazer held 922,933 shares of common stock.

Business combination of closing period

6 months

Business combination, deposited in to escrow account

$ 9,858,678

Business combination of sale business days

3 days

Forward Share Purchase Agreements | Glazer Capital, LLC | Letter of Credit and Reimbursement Agreement

Debt Instrument [Line Items]

Agreement collateral amount

$ 9,300,000

Forward Share Purchase Agreements | Glazer Capital, LLC | Common Stock

Debt Instrument [Line Items]

Closing of business combination share consideration

922,933

5,800

Forward Share Purchase Agreements | Nomura Global Financial Products

Debt Instrument [Line Items]

Business combination, share price

$ 10.50

Prepayment amount transferred to NGFP

$ 17,044,584

Number of days notice required for termination of agreement

10 days

Debt instrument interest rate percentage before original valuation date

2.75%

Debt instrument interest rate percentage after original valuation date

3.50%

Financial expense

$ 117,000

Forward Share Purchase Agreements | Nomura Global Financial Products | Common Stock

Debt Instrument [Line Items]

Business acquisition number of shares held

1,623,000

Forward Share Purchase Agreements | Nomura Global Financial Products | Maximum | Common Stock

Debt Instrument [Line Items]

Closing of business combination share consideration

2,000,000

Forward Share Purchase Agreements | Open Market | Greenhaven

Debt Instrument [Line Items]

Business combination, share price

$ 11.70

Number of days notice required for sale of shares under minimum block size condition

3 days

Exercise price of warrants, description

In the event that Greenhaven sells any shares (including any Additional Shares), at a sale price of less than $10.50, and provided that Greenhaven meets the Minimum Block Size Condition, it shall provide notice to the Company within three (3) Business Days of such sale, and such notice shall include the date of the sale, the number of shares sold, and confirmation that the sale price per share was greater than $8.50, and the Company shall pay Greenhaven in accordance with Greenhaven’s written instructions an amount equal to (x) the number of shares (including any Additional Shares) sold multiplied by (y) the amount by which $10.50 exceeds the sale price per share. Furthermore, the parties agreed that nothing in the Greenhaven Purchase Agreement shall prohibit Greenhaven from entering into a contract to purchase and/or sell warrants of Kaleyra, Inc.

Sale of stock price per unit

$ 8.50

Forward Share Purchase Agreements | Open Market | Greenhaven | Minimum

Debt Instrument [Line Items]

Business combination, share price

$ 10.50

Number of additional rights acquired under minimum block size condition

25,000

Exercise price of warrants under minimum block size condition

$ 8.50

Forward Share Purchase Agreements | Open Market | Kepos Alpha Fund L.P.

Debt Instrument [Line Items]

Number of days notice required for sale of shares under minimum block size condition

3 days

Exercise price of warrants, description

In the event that KAF sells any shares (including any Additional Shares), at a sale price of less than $10.50, and provided that KAF meets the Minimum Block Size Condition, it shall provide notice to the Company within three (3) Business Days of such sale, and such notice shall include the date of the sale, the number of shares sold, and confirmation that the sale price per share was greater than $8.50, and the Company shall pay KAF in accordance with KAF’s written instructions an amount equal to (x) the number of shares (including any Additional Shares) sold multiplied by (y) the amount by which $10.50 exceeds the sale price per share. Furthermore, the parties agreed that nothing in the KAF Purchase Agreement shall prohibit KAF from entering into a contract to purchase and/or sell warrants of the Company.

Forward Share Purchase Agreements | Open Market | Kepos Alpha Fund L.P. | Subsequent Event

Debt Instrument [Line Items]

Sale of stock price per unit

$ 7

Forward Share Purchase Agreements | Open Market | Kepos Alpha Fund L.P. | Minimum

Debt Instrument [Line Items]

Business combination, share price

$ 10.50

Exercise price of warrants under minimum block size condition

$ 8.50

Forward Share Purchase Agreements | Open Market | Glazer Capital, LLC

Debt Instrument [Line Items]

Number of days notice required for sale of shares under minimum block size condition

3 days

Exercise price of warrants, description

Glazer shall give written notice to the Company of any sale of shares (including any Additional Shares) within three (3) Business Days following the date of such sale, and such notice shall include the date of the sale, the number of shares sold, and confirmation that the sale price per share was greater than $10.50 per share (or greater than $8.50 per Share provided that Glazer meets the Minimum Block Size Condition) prior to the payment of any commissions due by Glazer for the sale.

Forward Share Purchase Agreements | Open Market | Glazer Capital, LLC | Minimum

Debt Instrument [Line Items]

Business combination, share price

$ 10.50

Exercise price of warrants under minimum block size condition

8.50

Forward Share Purchase Agreements, First right

Debt Instrument [Line Items]

Business combination, share price

$ 11

Business combination, shares acquired

196,195

Forward Share Purchase Agreements, Second Right

Debt Instrument [Line Items]

Business combination, share price

$ 10.70

Business combination, shares acquired

250,000

Forward Share Purchase Agreements, Third Right

Debt Instrument [Line Items]

Business combination, share price

$ 10.50

Business combination, shares acquired

550,000

Forward Share Purchase Agreements, First Right Additional Purchase | Kepos Alpha Fund L.P.

Debt Instrument [Line Items]

Business combination, share price

$ 10.70

Business combination, shares acquired

102,171

Forward Share Purchase Agreements, Second Right Additional Purchase | Kepos Alpha Fund L.P.

Debt Instrument [Line Items]

Business combination, share price

$ 10.50

Business combination, shares acquired

93,676

Forward Share Purchase Agreement Fourth Right | Kepos Alpha Fund L.P. | Subsequent Event

Debt Instrument [Line Items]

Business combination, share price

$ 10.92

Business combination, shares acquired

46,137

46,137

Forward Share Purchase Agreement Fifth Right | Kepos Alpha Fund L.P. | Subsequent Event

Debt Instrument [Line Items]

Business combination, share price

$ 10.82

$ 10.82

Business combination, shares acquired

93,676

93,676

Forward Share Purchase Agreement Sixth Right | Kepos Alpha Fund L.P. | Maximum | Subsequent Event

Debt Instrument [Line Items]

Business combination, share price

$ 10.92

Yakira First Amended Purchase Agreement | Yakira | Yakira Rights Shares

Debt Instrument [Line Items]

Business combination, share price

$ 10.93

$ 10.50

Business combination, number of shares expected to be purchase

43,930

Yakira Second Amended Purchase Agreement | Yakira | Subsequent Event

Debt Instrument [Line Items]

Number of rights shares to be purchased

43,930

Notes Payable - Additional Info

Notes Payable - Additional Information (Details) - USD ($)	Mar. 06, 2020	Nov. 25, 2019	Mar. 31, 2020
Debt Instrument [Line Items]
Notes, interest rate description			Interest on the Convertible Notes will accrue at a fixed interest rate equal to the one-year US dollar LIBOR interest rate published in The Wall Street Journal on the Business Combination Date, plus a margin of one percent (1%) per annum. Interest will be due and payable annually on each of (1) the date which is the twelve-month anniversary of the Business Combination Date and (2) on the date which is the twenty-four-month anniversary of the Business Combination Date. All interest shall be computed on the basis of a 365-day year and the actual number of days elapsed.
Contractual Interest Rate, Percentage			1.00%
Outstanding principal balance			50.00%
Number of business days after the Company receives such Payoff Financing Proceeds			10 days
Percentage of remaining outstanding principal balance			100.00%
Notes converted description			Convertible Notes are not paid in full on or before the applicable Maturity Date, then at any time after the sixtieth business day after the Maturity Date, assuming payment in full has not been made prior to such date, the outstanding principal amount of these Notes, together with all accrued but unpaid interest on these Convertible Notes, may be converted into shares of Company common stock, in part or in whole, at the option of the holder of these Convertible Notes by providing written notice at least three business days prior to the date of conversion.
Promissory Note | Northland Securities
Debt Instrument [Line Items]
Debt instrument face amount	$ 400,000
Interest Nominal Rate	8.00%
Debt instrument, maturity date	Dec. 31, 2020
Maximum
Debt Instrument [Line Items]
Contractual Interest Rate, Percentage			7.60%
Proceeds from equity financing			$ 50,000,000
Cash received from payoff financing proceeds			$ 75,000,000
Minimum
Debt Instrument [Line Items]
Contractual Interest Rate, Percentage			0.60%
Convertible Notes
Debt Instrument [Line Items]
Notes payable			$ 7,500,000
Accrued interest			$ 76,000
Non-convertible Notes
Debt Instrument [Line Items]
Notes, interest rate description			Interest on the Non-convertible Notes shall accrue at a fixed interest rate equal to LIBOR plus a margin of one percent (1%) per annum, which interest rate as of the date hereof is one and ninety-one hundredths percent (1.91%). As used herein, “LIBOR” means the one-year US Dollar LIBOR interest rate published in The Wall Street Journal on the Business Combination Date. All interest shall be computed on the basis of a 365-day year and the actual number of days elapsed.
Notes payable			$ 7,500,000
Accrued interest			$ 76,000
Notes, LIBOR interest rate			1.91%
Number of business days after the Company receives such Financing Proceeds			10 days
Non-convertible Notes | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Contractual Interest Rate, Percentage			1.00%
Non-convertible Notes | Maximum
Debt Instrument [Line Items]
Proceeds from equity financing			$ 11,500,000
Extension Notes and Working Capital Notes
Debt Instrument [Line Items]
Notes, interest rate description			Interest on the Amended Extension Notes and Amended Working Capital Notes will accrue at a fixed interest rate equal to the one-year U.S. dollar LIBOR interest rate published in The Wall Street Journal on the closing of the Business Combination, which is one and ninety-one hundredths percent (1.91%), plus a margin of one percent (1%) per annum. All interest shall be computed on the basis of a 365-day year and the actual number of days elapsed.
Notes payable			$ 3,600,000
Notes, LIBOR interest rate			1.91%
Number of business days after the Company receives such Financing Proceeds			10 days
Notes payable due to related parties			$ 1,900,000
Extension Notes and Working Capital Notes | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Contractual Interest Rate, Percentage			1.00%
Extension Notes and Working Capital Notes | Maximum
Debt Instrument [Line Items]
Proceeds from equity financing			$ 11,500,000
Esse Effe S.p.A
Debt Instrument [Line Items]
Cash consideration		$ 6,000,000
Maya
Debt Instrument [Line Items]
Cash consideration		$ 1,500,000

Preference Shares Liabilities -

Preference Shares Liabilities - Additional Information (Details)	Mar. 24, 2020Employee	Mar. 09, 2020INR (₨)	Mar. 31, 2020USD ($)$ / shares	Feb. 29, 2020₨ / shares	Jan. 31, 2020USD ($)	Dec. 31, 2019USD ($)$ / shares
Preference Shares Liabilities [Line Items]
Preferred stock, par value | $ / shares			$ 0.0001			$ 0.0001
Solutions Infini Purchase Agreement
Preference Shares Liabilities [Line Items]
Preference share liabilities			$ 2,000			$ 2,500,000
Modification of 2018 Solutions Infini Purchase Agreement | COVID-19 | Preferred Stock
Preference Shares Liabilities [Line Items]
Preference shares, performance bonuses					$ 1,400,000
Number of employees get delay payment of performance bonuses | Employee	2
Modification of 2018 Solutions Infini Purchase Agreement | Solutions Infini
Preference Shares Liabilities [Line Items]
Preferred stock, par value | ₨ / shares				₨ 10
Preferred share obligation		₨ 132,000	$ 2,000
Performance bonuses to be paid date, year		2020
Modification of 2018 Solutions Infini Purchase Agreement | Solutions Infini | COVID-19 | Preferred Stock
Preference Shares Liabilities [Line Items]
Preference shares, performance bonuses					$ 3,500,000

Other Current and Long-Term L_3

Other Current and Long-Term Liabilities - Other Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Other Liabilities Current [Abstract]
Liabilities for tax other than income tax	$ 1,038	$ 583
Social securities liabilities	184	256
Accrued financial interest	413	149
Other liabilities	388	391
Total other current liabilities	$ 2,023	$ 1,379

Other Current and Long-Term L_4

Other Current and Long-Term Liabilities - Other Long-Term Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Other Liabilities Noncurrent [Abstract]
Payable to supplier	$ 2,700	$ 2,700
Long-term performance bonuses	1,433
Derivative contract liabilities	73	80
Other long-term liabilities	393	375
Total other long-term liabilities	$ 4,599	$ 3,155

Geographic Information - Summar

Geographic Information - Summary of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Segment Reporting Information [Line Items]
Revenue	$ 33,633	$ 27,725
Italy
Segment Reporting Information [Line Items]
Revenue	$ 14,608	$ 13,408
Italy | Geographic Concentration Risk | Revenue
Segment Reporting Information [Line Items]
Concentration risk percentage	43.40%	48.40%
India
Segment Reporting Information [Line Items]
Revenue	$ 8,893	$ 8,171
India | Geographic Concentration Risk | Revenue
Segment Reporting Information [Line Items]
Concentration risk percentage	26.40%	29.50%
United States
Segment Reporting Information [Line Items]
Revenue	$ 4,289	$ 1,692
United States | Geographic Concentration Risk | Revenue
Segment Reporting Information [Line Items]
Concentration risk percentage	12.80%	6.10%
Europe (excluding Italy)
Segment Reporting Information [Line Items]
Revenue	$ 2,573	$ 3,598
Europe (excluding Italy) | Geographic Concentration Risk | Revenue
Segment Reporting Information [Line Items]
Concentration risk percentage	7.70%	13.00%
Rest of the World
Segment Reporting Information [Line Items]
Revenue	$ 3,270	$ 856
Rest of the World | Geographic Concentration Risk | Revenue
Segment Reporting Information [Line Items]
Concentration risk percentage	9.70%	3.00%

Geographic Information - Summ_2

Geographic Information - Summary of Long-lived Assets by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Long-lived assets	$ 3,888	$ 3,393
Italy
Segment Reporting Information [Line Items]
Long-lived assets	$ 1,965	$ 1,772
Italy | Geographic Concentration Risk | Long-Lived Assets
Segment Reporting Information [Line Items]
Long-lived assets, Percentage	50.50%	52.20%
India
Segment Reporting Information [Line Items]
Long-lived assets	$ 1,115	$ 1,162
India | Geographic Concentration Risk | Long-Lived Assets
Segment Reporting Information [Line Items]
Long-lived assets, Percentage	28.70%	34.20%
United States
Segment Reporting Information [Line Items]
Long-lived assets	$ 787	$ 437
United States | Geographic Concentration Risk | Long-Lived Assets
Segment Reporting Information [Line Items]
Long-lived assets, Percentage	20.30%	12.90%
Rest of the World
Segment Reporting Information [Line Items]
Long-lived assets	$ 21	$ 22
Rest of the World | Geographic Concentration Risk | Long-Lived Assets
Segment Reporting Information [Line Items]
Long-lived assets, Percentage	0.50%	0.70%

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Other Commitments [Line Items]
Operating lease, rent expense	$ 309,000	$ 196,000
Amount of contingent liabilities payable	126,000
Provision for contingent liabilities	$ 0
Milan office
Other Commitments [Line Items]
Operating lease, option to renew	true
Operating lease, renewal term	6 years

Commitments and Contingencies_2

Commitments and Contingencies - Schedule of Future Minimum Lease Payments under Operating Leases (Details) $ in Thousands	Mar. 31, 2020USD ($)
Operating Lease Liabilities Payments Due [Abstract]
2020 (remaining nine months)	$ 541
2021	527
2022	508
2023	400
2024	312
2025 and thereafter	416
Total Minimum Lease Payments	$ 2,704

Restricted Stock Units - Additi

Restricted Stock Units - Additional Information (Details) - USD ($) $ in Thousands	Mar. 24, 2020	Mar. 31, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares granted	113,506
Award vesting period	3 years
Restricted Stock Units (RSUs)
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares granted		113,506
Compensation expense		$ 6,204
Unrecognized compensation cost		$ 19,200
Unrecognized compensation cost weighted-average remaining period		1 year 6 months 18 days
Within February 1, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Award vesting rights, percentage	25.00%
Three-year Period Starting from February 1, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Award vesting rights, percentage	75.00%

Restricted Stock Units - Summar

Restricted Stock Units - Summary of Outstanding RSUs (Details) - $ / shares	Mar. 24, 2020	Mar. 31, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares, Shares granted	113,506
Restricted Stock Units (RSUs)
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares, Non-vested as of December 31, 2019		3,336,095
Number of shares, Shares vested		(137,104)
Number of shares, Shares granted		113,506
Number of shares, Shares cancelled		(132,897)
Number of shares, Non-vested as of March 31, 2020		3,179,600
Weighted-average grant date fair value (per share), Non-vested as of December 31, 2019		$ 8.25
Weighted-average grant date fair value (per share), Vested		8.25
Weighted-average grant date fair value (per share), Granted		6.23
Weighted-average grant date fair value (per share), Cancelled		8.25
Weighted-average grant date fair value (per share), Non-vested as of March 31, 2020		$ 8.18

Restricted Stock Units - Summ_2

Restricted Stock Units - Summary of RSUs Compensation Expense (Details) - Restricted Stock Units (RSUs) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total	$ 6,204
Research and Development
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total	1,312
Sales and Marketing
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total	1,053
General and Administrative
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total	$ 3,839

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Taxes [Line Items]
Income tax expense (benefit)	$ (589,000)	$ 79,000
Open tax year	2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Solutions Infini
Income Taxes [Line Items]
Undistributed earnings and profits by foreign subsidiary	$ 2,100,000
Undistributed profits	0
Expected tax expense due to undistributed earnings	$ 321,000

Net Loss Per Share - Schedule o

Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Earnings Per Share [Abstract]
Net loss		$ (8,823)	$ (1,379)
Weighted-average shares used in computing net loss per common share basic and diluted	[1]	19,979,589	10,687,106
Net loss per common share basic and diluted	[1]	$ (0.44)	$ (0.13)
[1]	Amounts for the three months ended March 31, 2019 were retrospectively adjusted as a result of the accounting for the Business Combination (as defined below in the notes). Specifically, the number of common shares outstanding during periods before the Business Combination are computed on the basis of the number of common shares of Kaleyra S.p.A. (accounting acquiror) during those periods multiplied by the exchange ratio established in the stock purchase agreement. Common stock and net loss per share, basic and diluted were retrospectively adjusted accordingly.

Net Loss Per Share - Additional

Net Loss Per Share - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 12, 2017
Class Of Stock [Line Items]
Weighted-average number of outstanding shares of common stock excluded from calculation of diluted net loss per share	14,346,056	0
Warrants
Class Of Stock [Line Items]
Business combination, share price	$ 11.50		$ 11.50
Warrant agreement date	Dec. 12, 2017
Number of fractional shares issued upon exercise of warrants	0
Period after business combination when warrants become exercisable	30 days
Warrants exercisable expiration period after completion of business combination	5 years
Net cash settlement value of warrants	$ 0
Redemption price per warrant	$ 0.01
Minimum period of prior written notice of redemption of warrants	30 days
Minimum price per share required for redemption of warrants	$ 18
Warrants redemption covenant, threshold trading days	20 days
Warrants redemption covenant, threshold consecutive trading days	30 days
Warrants or rights outstanding	11,154,938

Transactions with Related Par_3

Transactions with Related Parties - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Related Party Transaction [Line Items]
Notes payable outstanding amount due	$ 13,115,000		$ 9,411,000
Studio Legale Chiomenti | Legal Services
Related Party Transaction [Line Items]
Cost incurred for related party services	56,000	$ 0
Directors and Executive Managers
Related Party Transaction [Line Items]
Outstanding amount of loans granted	21,000		22,000
Executive Managers
Related Party Transaction [Line Items]
Outstanding obligation for preference shares	1,000		1,800,000
Esse Effe and Maya
Related Party Transaction [Line Items]
Notes payable outstanding amount due	15,000,000		15,000,000
Sponsor and Gig Founders, LLC
Related Party Transaction [Line Items]
Notes payable outstanding amount due	1,900,000		1,900,000
Accrued Interest | Esse Effe and Maya
Related Party Transaction [Line Items]
Notes payable outstanding amount due	152,000		43,000
Accrued Interest | Sponsor and Gig Founders, LLC
Related Party Transaction [Line Items]
Notes payable outstanding amount due	$ 19,000		$ 5,000

Transactions with Related Par_4

Transactions with Related Parties - Schedule of Expenses for Related Parties (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Research and Development
Related Party Transaction [Line Items]
Expenses for related parties		$ 94
General and Administrative
Related Party Transaction [Line Items]
Expenses for related parties	$ 56	$ 94
Financial Income (Expense), Net
Related Party Transaction [Line Items]
Expenses for related parties	$ 122

Revenue - Additional Informatio

Revenue - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Disaggregation Of Revenue [Abstract]
Revenue from usage-based fees in total revenue	98.00%	99.00%
Revenue from term-based fees in total revenue	2.00%	1.00%
Deferred revenue	$ 1,500,000		$ 1,400,000
Deferred revenue, revenue recognized	$ 647,000

Subsequent Events - Additional

Subsequent Events - Additional Information (Details)	May 01, 2020USD ($)shares	Apr. 24, 2020USD ($)	Apr. 16, 2020USD ($)d$ / shares	Apr. 09, 2020USD ($)shares	Apr. 07, 2020USD ($)	Mar. 31, 2020USD ($)$ / sharesshares	Apr. 29, 2020$ / sharesshares	Dec. 31, 2019USD ($)$ / sharesshares	Dec. 12, 2017$ / shares
Subsequent Event [Line Items]
Amounts owed to Service Firms						$ 13,100,000
Common stock value						$ 2,000		$ 2,000
Common stock, shares issued | shares						20,254,217		19,977,113
Common stock, par value | $ / shares						$ 0.0001		$ 0.0001	$ 0.0001
Warrants issued | shares	0
Cowen Investments and Chardan
Subsequent Event [Line Items]
Aggregate settlement of investment shares | shares	440,595
Debt instrument face amount	$ 2,700,000
Cowen Investments
Subsequent Event [Line Items]
Aggregate settlement of investment shares | shares	374,506
Debt instrument face amount	$ 2,300,000
Conversion of common stock shares | shares	303,171
Chardan
Subsequent Event [Line Items]
Aggregate settlement of investment shares | shares	66,089
Debt instrument face amount	$ 405,000
Conversion of common stock shares | shares	53,501
Subsequent Event
Subsequent Event [Line Items]
Line of credit facility payment		$ 350,000
Common stock, par value | $ / shares							$ 0.0001
Common stock grant date value per share | $ / shares							$ 7
Subsequent Event | Earnout Shares
Subsequent Event [Line Items]
Common stock, shares issued | shares							1,763,633
Subsequent Event | Kepos Alpha Fund L.P.
Subsequent Event [Line Items]
Repurchases of common stock, shares | shares				50,000
Repurchases of common stock, value				$ 500,000
Subsequent Event | Cowen and Company, LLC and Chardan Capital markets, LLC
Subsequent Event [Line Items]
Amounts owed to Service Firms			$ 5,400,000
Subsequent Event | Cowen and Company, LLC and Chardan Capital markets, LLC | Resale Registration Statement
Subsequent Event [Line Items]
Common stock value			$ 2,700,000
Warrants exercise price | $ / shares			$ 0.01
Beneficial ownership limitation percentage			4.99%
Settlement shares, threshold percentage			15.00%
Settlement shares, trailing days | d			10
Subsequent Event | Cowen and Company, LLC and Chardan Capital markets, LLC | Resale Registration Statement | Convertible Notes
Subsequent Event [Line Items]
Convertible notes			$ 2,700,000
Debt instrument, term			3 years
Repaid earlier interest rate issuance term			1 year
Repaid after interest rate issuance term			2 years
Interest rate			5.00%
Convertible notes, threshold percentage			5.00%
Convertible notes, trailing days | d			10
Kaleyra S.p.A | Unicredit | Subsequent Event
Subsequent Event [Line Items]
Deferment of debt repayments to next 12 months				$ 1,600,000	$ 694,000